##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.2-194-g7c09584
##SAMPLE=<ID=NA12878_45,Gender=n/a,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=NA12878_45=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_45	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	SpliceAI	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	27687466	27687466	G	T	het		QUAL=9721;DP=729;AF=0.52;MQM=60;SAP=4;ABP=5	MAP3K6	missense	MAP3K6:ENST00000357582.2:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:ENST00000374040.3:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:,MAP3K6:ENST00000493901.1:missense_variant:MODERATE:exon15/30:c.1866C>A:p.Asn622Lys:	MAP3K6:NM_001297609.2:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:,MAP3K6:NM_004672.5:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:			403071 [benign DISEASE=not specified];			rs35659744	0.1220	0.2260	892,.	0.0497,0.1399,0.0936,0.3028,0.1508	0.0290	T(0.18),T(0.20),T(0.18)	B(0.00),B(0.00),B(0.00)	0.03,0.20	13.69	0.04			COSV62889375	0.1192	0.1097	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahchera1 17.06.2021"		"3"	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	45797505	45797505	C	G	het		QUAL=3110;DP=231;AF=0.51;MQM=60;SAP=5;ABP=3	MUTYH	missense,intron	MUTYH:ENST00000354383.6:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:ENST00000355498.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000372098.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372100.5:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000372104.1:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:ENST00000372110.3:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:ENST00000372115.3:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000448481.1:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000450313.1:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His:,MUTYH:ENST00000456914.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000488731.2:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000528013.2:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000528332.2:intron_variant:MODIFIER:intron3/6:c.230-277G>C::,MUTYH:ENST00000529984.1:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000531105.1:intron_variant:MODIFIER:intron2/2:c.116-2396G>C::	MUTYH:NM_001048171.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:NM_001048172.1:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:NM_001048173.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001048174.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001128425.1:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His:,MUTYH:NM_001293190.1:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:NM_001293191.1:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:NM_001293192.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001293195.1:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:NM_001293196.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001350650.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_001350651.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_012222.2:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:NR_146882.1:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.1188G>C::,MUTYH:NR_146883.1:non_coding_transcript_exon_variant:MODIFIER:exon11/16:n.1002G>C::		618994 [GENE=HPDL PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,619026,Autosomal recessive/Spastic paraplegia 83,autosomal recessive,619027,Autosomal recessive],604933 [GENE=MUTYH PHENOS=Adenomas,multiple colorectal,608456,Autosomal recessive/Gastric cancer,somatic,613659];	41767 [benign DISEASE=Carcinoma of colon,MYH-associated polyposis,Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,not specified,none provided,not provided];	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH];		rs3219489	0.3135	0.2900	1071,.	0.2630,0.4881,0.3974,0.2444,0.2371	0.0510	T(0.10),T(0.10),T(0.08),T(0.09),T(0.10),T(0.09),T(0.08),T(0.09),T(0.07),T(0.10), ,T(0.08), , , 	B(0.15),B(0.21),B(0.29),B(0.29),B(0.21),B(0.38),B(0.21),B(0.29),B(0.21),B(0.21), ,B(0.21), , , 	0.15,0.62	12.97	0.04				0.0714	0.9516	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfdfdfdf"	HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	62713224	62713224	C	G	hom		QUAL=1165;DP=37;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	missense	KANK4:ENST00000317477.4:missense_variant:MODERATE:exon3/4:c.217G>C:p.Val73Leu:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.1:missense_variant:MODERATE:exon6/7:c.871G>C:p.Val291Leu:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153.4:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:,KANK4:NM_181712.5:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:			1257820 [benign DISEASE=not provided];			rs2941679		0.9750	14912,.	0.9936,0.9872,0.9993,0.9639,0.9725	0.6970	T(0.37),T(0.28),T(0.31),T(0.94)	B(0.00),B(0.00),B(0.00),B(0.00)	0.42,0.96	15.77	0.04				-0.0002	0.1727	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"sdsdsdsd"	KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62713246	62713246	G	A	het		QUAL=1311;DP=117;AF=0.44;MQM=60;SAP=3;ABP=7	KANK4	synonymous	KANK4:ENST00000317477.4:synonymous_variant:LOW:exon3/4:c.195C>T:p.His65=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.1:synonymous_variant:LOW:exon6/7:c.849C>T:p.His283=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153.4:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:			1272744 [benign DISEASE=not provided];			rs10889315	0.3189	0.3893	2423,.	0.3207,0.3324,0.1573,0.4246,0.4067	-0.5170			0.15,0.93	4.66					-0.0649	0.1708	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfgdfgdfgdg"	KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728784	62728784	A	G	hom		QUAL=38141;DP=1196;AF=1.00;MQM=60;SAP=5;ABP=0	KANK4	5'UTR,missense	KANK4:ENST00000317477.4:5_prime_UTR_variant:MODIFIER:exon1/4:c.-68T>C::,KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.1:missense_variant:MODERATE:exon4/7:c.587T>C:p.Val196Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153.4:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:,KANK4:NM_181712.5:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:			1239401 [benign DISEASE=not provided];			rs2666472		0.7540	8118,.	0.5500,0.8594,0.8461,0.7369,0.7029	2.8410	 ,T(0.32),T(0.35),T(0.93)	 ,B(0.04),B(0.06),B(0.06)	0.78,0.95	11.20	0.16				-0.0205	0.46	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728838	62728838	T	C	hom		QUAL=35318;DP=1135;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	5'UTR,missense	KANK4:ENST00000317477.4:5_prime_UTR_variant:MODIFIER:exon1/4:c.-122A>G::,KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.1:missense_variant:MODERATE:exon4/7:c.533A>G:p.His178Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153.4:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:PF12796 [Ankyrin repeats (3 copies)]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:,KANK4:NM_181712.5:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:	regulatory_region_variant:enhancer		1270534 [benign DISEASE=not provided];			rs2258470		0.7541	8086,.	0.5508,0.8597,0.8459,0.7369,0.7029	3.3080	 ,T(0.41),T(0.43),T(0.22)	 ,B(0.00),B(0.00),B(0.00)	0.14,0.94	14.79	0.10				0.0359	0.4629	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728861	62728861	T	C	hom		QUAL=35829;DP=1143;AF=1.00;MQM=60;SAP=5;ABP=0	KANK4	5'UTR,synonymous	KANK4:ENST00000317477.4:5_prime_UTR_variant:MODIFIER:exon1/4:c.-145A>G::,KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:,KANK4:ENST00000371150.1:synonymous_variant:LOW:exon4/7:c.510A>G:p.Lys170=:,KANK4:ENST00000371153.4:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:	KANK4:NM_001320269.2:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:	regulatory_region_variant:enhancer		1295500 [benign DISEASE=not provided];			rs2260581		0.7543	8089,.	0.5516,0.8598,0.8461,0.7373,0.7029	0.5670			0.03,0.94	10.34					0.1288	0.4678	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62728918	62728918	G	A	hom		QUAL=5604;DP=187;AF=1.00;MQM=60;SAP=31;ABP=0	KANK4	5'UTR,synonymous	KANK4:ENST00000317477.4:5_prime_UTR_variant:MODIFIER:exon1/4:c.-202C>T::,KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:,KANK4:ENST00000371150.1:synonymous_variant:LOW:exon4/7:c.453C>T:p.Pro151=:,KANK4:ENST00000371153.4:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:	KANK4:NM_001320269.2:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:	regulatory_region_variant:enhancer		1262248 [benign DISEASE=not provided];			rs2262110	0.7161	0.7545	8119,.	0.5517,0.8595,0.8467,0.7377,0.7028	-1.7560			0.04,0.94	3.89					-0.0241	0.4598	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62732421	62732421	T	C	het		QUAL=11398;DP=885;AF=0.52;MQM=60;SAP=3;ABP=5	KANK4	missense	KANK4:ENST00000354381.3:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:ENST00000371150.1:missense_variant:MODERATE:exon3/7:c.370A>G:p.Thr124Ala:,KANK4:ENST00000371153.4:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:	KANK4:NM_001320269.2:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:NM_181712.5:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:			1295514 [benign DISEASE=not provided];			rs11207949	0.3055	0.2967	1353,.	0.2153,0.4784,0.5863,0.2438,0.1437	2.3800	T(0.55),T(0.54),T(0.12)	B(0.01),B(0.01),B(0.01)	0.76,0.33	14.21	0.02				0.1201	0.7193	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62738904	62738904	T	C	hom		QUAL=1844;DP=63;AF=1.00;MQM=60;SAP=9;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:ENST00000371153.4:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:	regulatory_region_variant:promoter_flanking_region		1265012 [benign DISEASE=not provided];			rs7516290	0.8005	0.7709	9393,.	0.8562,0.8321,0.8485,0.6898,0.7526	-0.8540			0.05,0.20	1.43					0.0065	0.5269	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62739198	62739198	G	A	het		QUAL=1755;DP=140;AF=0.49;MQM=60;SAP=10;ABP=3	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:ENST00000371153.4:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:	regulatory_region_variant:promoter_flanking_region		1270734 [benign DISEASE=not provided];			rs17855078	0.2506	0.3037	1292,.	0.1791,0.2220,0.1264,0.3399,0.4044	-1.6330			0.07,0.11	0.04					-0.0137	0.5258	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62740065	62740065	A	G	het		QUAL=1454;DP=128;AF=0.48;MQM=60;SAP=3;ABP=4	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:ENST00000371153.4:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:			1265023 [benign DISEASE=not provided];			rs12127930	0.4822	0.4851	3833,.	0.6174,0.3608,0.2619,0.4397,0.5676	-1.6810			0.05,0.15	0.58					0.0154	0.5273	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62740446	62740446	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:ENST00000371153.4:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:			1262658 [benign DISEASE=not provided];			rs2666506	0.8045	0.7703	9309,.	0.8578,0.8402,0.8658,0.6865,0.7418	0.0250			0.00,0.20	2.54					0.0056	0.5268	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62740449	62740449	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:ENST00000371153.4:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:			1182584 [benign DISEASE=not provided];			rs2666507	0.7809	0.7459	8702,.	0.7750,0.8364,0.8658,0.6862,0.7416	-1.5990			0.04,0.10	0.09					0.0049	0.5268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	120458004	120458004	A	T	het		QUAL=1766;DP=130;AF=0.55;MQM=60;SAP=3;ABP=6	NOTCH2	synonymous	NOTCH2:ENST00000256646.2:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:	NOTCH2:NM_024408.4:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:		600275 [GENE=NOTCH2 PHENOS=Alagille syndrome 2,610205,Autosomal dominant/Hajdu-Cheney syndrome,102500,Autosomal dominant];	261705 [benign DISEASE=Hajdu-Cheney syndrome,not specified,not provided];			rs6685892	0.1925	0.1688	594,.	0.3365,0.0881,0.0295,0.1028,0.1890	-0.5740			0.09,0.21	5.88					0.0062	0.8881	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120539331	120539331	C	T	het	low_conf_region	QUAL=25003;DP=1918;AF=0.52;MQM=49;SAP=4;ABP=7	NOTCH2	intron,missense	NOTCH2:ENST00000256646.2:intron_variant:MODIFIER:intron4/33:c.751+289G>A::,NOTCH2:ENST00000602566.1:missense_variant:MODERATE:exon6/6:c.673G>A:p.Gly225Arg:	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron4/21:c.751+289G>A::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron4/33:c.751+289G>A::	regulatory_region_variant:promoter_flanking_region	600275 [GENE=NOTCH2 PHENOS=Alagille syndrome 2,610205,Autosomal dominant/Hajdu-Cheney syndrome,102500,Autosomal dominant];				rs2124109		0.4374	0,.	0.2349,0.4172,0.4612,0.4569,0.4527	-0.7660	 ,T(0.93)	 ,P(0.55)	0.02,0.14	7.74					0.0088	0.9488	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120611496	120611496	C	A	het	low_conf_region	QUAL=276;DP=41;AF=0.49;MQM=47;SAP=46;ABP=3	NOTCH2	intron	NOTCH2:ENST00000256646.2:intron_variant:MODIFIER:intron1/33:c.73+452G>T::	NOTCH2:NM_001200001.1:intron_variant:MODIFIER:intron1/21:c.73+452G>T::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron1/33:c.73+452G>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Alagille syndrome 2,610205,Autosomal dominant/Hajdu-Cheney syndrome,102500,Autosomal dominant];				rs2794164		0.4987	876,.	0.5084,0.2885,0.4209,0.2317,0.2388	0.1850			0.00,0.10	8.09							0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120611960	120611960	C	T	het	low_conf_region	QUAL=4716;DP=1928;AF=0.21;MQM=47;SAP=3;ABP=1406	NOTCH2	missense	NOTCH2:ENST00000256646.2:missense_variant:MODERATE:exon1/34:c.61G>A:p.Ala21Thr:	NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.61G>A:p.Ala21Thr:,NOTCH2:NM_024408.4:missense_variant:MODERATE:exon1/34:c.61G>A:p.Ala21Thr:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Alagille syndrome 2,610205,Autosomal dominant/Hajdu-Cheney syndrome,102500,Autosomal dominant];	1240631 [benign DISEASE=not specified,not provided];			rs2603926		0.1154	0,.	0.1924,0.0615,0.0501,0.1505,0.0930	0.4330	T(0.57)	B(0.01)	0.26,0.89	16.28	0.05			COSV56681399	0.0235	0.0735	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120611964	120611964	G	C	het	low_conf_region	QUAL=16670;DP=1962;AF=0.38;MQM=59;SAP=8;ABP=229	NOTCH2	missense	NOTCH2:ENST00000256646.2:missense_variant:MODERATE:exon1/34:c.57C>G:p.Cys19Trp:	NOTCH2:NM_001200001.1:missense_variant:MODERATE:exon1/22:c.57C>G:p.Cys19Trp:,NOTCH2:NM_024408.4:missense_variant:MODERATE:exon1/34:c.57C>G:p.Cys19Trp:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Alagille syndrome 2,610205,Autosomal dominant/Hajdu-Cheney syndrome,102500,Autosomal dominant];	801540 [benign DISEASE=Hajdu-Cheney syndrome,not specified];			rs11810554		0.4434	0,.	0.2583,0.4276,0.4668,0.4595,0.4561	0.7670	T(0.18)	B(0.00)	0.33,0.90	21.30	0.10			COSV56680365	-0.0776	0.0721	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120612006	120612006	G	A	het	low_conf_region	QUAL=19826;DP=2005;AF=0.39;MQM=58;SAP=4;ABP=217	NOTCH2	synonymous	NOTCH2:ENST00000256646.2:synonymous_variant:LOW:exon1/34:c.15C>T:p.Arg5=:	NOTCH2:NM_001200001.1:synonymous_variant:LOW:exon1/22:c.15C>T:p.Arg5=:,NOTCH2:NM_024408.4:synonymous_variant:LOW:exon1/34:c.15C>T:p.Arg5=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Alagille syndrome 2,610205,Autosomal dominant/Hajdu-Cheney syndrome,102500,Autosomal dominant];	1174922 [benign DISEASE=not specified];			rs4021006	0.3940	0.4509	92,.	0.2970,0.4472,0.4622,0.4601,0.4676	1.0740			0.19,0.89	13.37				COSV56680229,COSV56680371	0.0458	0.0739	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	120612034	120612034	T	G	het	low_conf_region	QUAL=3626;DP=2011;AF=0.20;MQM=47;SAP=3;ABP=1566	NOTCH2	5'UTR	NOTCH2:ENST00000256646.2:5_prime_UTR_variant:MODIFIER:exon1/34:c.-14A>C::	NOTCH2:NM_001200001.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-14A>C::,NOTCH2:NM_024408.4:5_prime_UTR_variant:MODIFIER:exon1/34:c.-14A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600275 [GENE=NOTCH2 PHENOS=Alagille syndrome 2,610205,Autosomal dominant/Hajdu-Cheney syndrome,102500,Autosomal dominant];			(CGC)n (Simple_repeat)	rs201668322		0.0593	0,.	0.0749,0.0289,0.0310,0.0881,0.0341	0.2430			0.16,0.88	15.76					-0.0062	0.0731	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr2	17942775	17942775	T	A	hom		QUAL=3038;DP=92;AF=1.00;MQM=60;SAP=14;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.7:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],GEN1:ENST00000381254.2:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],SMC6:ENST00000402989.1:intron_variant:MODIFIER:intron4/29:c.-5-15557A>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:NM_182625.5:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:			1169875 [benign DISEASE=not provided];			rs1812152		0.7177	7473,.	0.7654,0.8383,0.9844,0.6243,0.8734	0.5660	T(0.36),T(0.36), 	B(0.00),B(0.00), 	0.02,0.90	12.41	0.03				0.0628	0.9187	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17954027	17954027	G	A	hom		QUAL=972;DP=30;AF=1.00;MQM=60;SAP=22;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.7:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:ENST00000381254.2:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,SMC6:ENST00000402989.1:intron_variant:MODIFIER:intron4/29:c.-6+15055C>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:NM_182625.5:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:			1169876 [benign DISEASE=not provided];			rs300175	0.9770	0.9944	15324,.	0.9515,0.9973,0.9998,0.9999,0.9842	-2.1940	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.01,0.10	0.00	0.02				0.0986	0.3022	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17962450	17962450	A	G	hom		QUAL=3083;DP=96;AF=1.00;MQM=60;SAP=84;ABP=0	GEN1,SMC6	synonymous,intron	GEN1:ENST00000317402.7:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:ENST00000381254.2:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,SMC6:ENST00000402989.1:intron_variant:MODIFIER:intron4/29:c.-6+6632T>C::	GEN1:NM_001130009.3:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:NM_182625.5:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:			1169877 [benign DISEASE=not provided];			rs300168	0.5739	0.5891	3679,.	0.2165,0.7466,0.9232,0.5153,0.7680	0.4800			0.72,0.96	10.34					-0.0013	0.8753	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17962518	17962518	C	T	hom		QUAL=3598;DP=112;AF=1.00;MQM=60;SAP=3;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.7:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:ENST00000381254.2:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,SMC6:ENST00000402989.1:intron_variant:MODIFIER:intron4/29:c.-6+6564G>A::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:NM_182625.5:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:			1169878 [benign DISEASE=not provided];			rs300169		0.7049	6505,.	0.5958,0.8273,0.9846,0.6234,0.8730	0.1800	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.00,0.16	8.92	0.05				-0.0058	0.8752	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	47601106	47601106	T	C	het		QUAL=747;DP=42;AF=0.71;MQM=60;SAP=3;ABP=20	EPCAM	missense	EPCAM:ENST00000263735.4:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:PF00086 [Thyroglobulin type-1 repeat],EPCAM:ENST00000405271.1:missense_variant:MODERATE:exon4/10:c.428T>C:p.Met143Thr:PF00086 [Thyroglobulin type-1 repeat]	EPCAM:NM_002354.3:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	185535 [GENE=EPCAM PHENOS=Colorectal cancer,hereditary nonpolyposis,type 8,613244/Diarrhea 5,with tufting enteropathy,congenital,613217,Autosomal recessive];	183700 [benign DISEASE=Lynch syndrome I,Diarrhea 5, with tufting enteropathy, congenital,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs1126497	0.6661	0.6003	6090,.	0.8418,0.4720,0.8320,0.4359,0.4807	0.0410	T(1.00),T(1.00)	B(0.00),B(0.00)	0.08,0.17	11.56	0.18				0.0873	0.9348	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	48010488	48010488	G	A	het		QUAL=143;DP=14;AF=0.50;MQM=60;SAP=3;ABP=3	MSH6	missense	MSH6:ENST00000234420.5:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000540021.1:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:	MSH6:NM_000179.2:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:NM_001281492.1:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:,MSH6:NM_001281493.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-621G>A::	regulatory_region_variant:promoter	600678 [GENE=MSH6 PHENOS=Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant/Mismatch repair cancer syndrome 3,619097,Autosomal recessive/Endometrial cancer,familial,608089,Autosomal dominant,Somatic mutation];	36581 [benign DISEASE=Breast carcinoma,Carcinoma of colon,Lynch syndrome,Lynch syndrome I,Hereditary nonpolyposis colorectal cancer type 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,none provided,not provided];	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6];		rs1042821	0.2009	0.1893	556,.	0.2215,0.1042,0.2531,0.1809,0.2120	1.7020	T(1.00),T(0.62)	B(0.00),B(0.00)	0.05,0.69	12.17	0.16			COSV52274018	0.0502	0.6269	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34)
chr2	48030692	48030692	T	A	het		QUAL=247;DP=17;AF=0.65;MQM=60;SAP=27;ABP=6	MSH6,FBXO11	synonymous,intron	MSH6:ENST00000234420.5:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:PF00488 [MutS domain V],FBXO11:ENST00000405808.1:intron_variant:MODIFIER:intron3/3:c.169+4642A>T::,MSH6:ENST00000538136.1:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800=:PF00488 [MutS domain V],MSH6:ENST00000540021.1:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:PF00488 [MutS domain V]	MSH6:NM_000179.2:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:,MSH6:NM_001281492.1:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:,MSH6:NM_001281493.1:synonymous_variant:LOW:exon4/9:c.2400T>A:p.Thr800=:,MSH6:NM_001281494.1:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800=:		600678 [GENE=MSH6 PHENOS=Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant/Mismatch repair cancer syndrome 3,619097,Autosomal recessive/Endometrial cancer,familial,608089,Autosomal dominant,Somatic mutation],607871 [GENE=FBXO11 PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];	36589 [benign DISEASE=Carcinoma of colon,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs2020910	0.0493	0.0203	22,.	0.0080,0.0137,0.2030,0.0017,0.0080	-2.3650			0.11,0.41	1.81					-0.018	0.1869	0.02	6	272	1 / 52	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	215595164	215595164	G	A	het		QUAL=261;DP=27;AF=0.44;MQM=60;SAP=4;ABP=4	BARD1	missense	BARD1:ENST00000260947.4:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:ENST00000432456.1:missense_variant:MODERATE:exon2/3:c.85C>T:p.Arg29Cys:,BARD1:ENST00000449967.2:missense_variant:MODERATE:exon9/10:c.1540C>T:p.Arg514Cys:	BARD1:NM_000465.4:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:,BARD1:NM_001282545.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:,BARD1:NM_001282548.2:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:,BARD1:NM_001282549.2:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.1937C>T::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon8/9:n.1880C>T::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.1136C>T::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation];	136500 [likely benign(replaced by megSAP based on classifications:7x1,4x2,1x3) DISEASE=Malignant tumor of breast,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Triple-Negative Breast Cancer Finding,not specified,not provided];	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1];		rs3738888	0.0054	0.0084	1,.	0.0020,0.0125,0.0115,0.0087,0.0041	5.1660	D(0.00),D(0.00),D(0.00)	B(0.36),B(0.37),B(0.29)	0.98,0.99	26.40	0.10				-0.1567	0.8792	0.01	1	323	0 / 55	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215632255	215632255	C	T	het		QUAL=3056;DP=110;AF=0.55;MQM=60;SAP=29;ABP=6	BARD1	missense	BARD1:ENST00000260947.4:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:PF00023 [Ankyrin repeat],BARD1:ENST00000449967.2:missense_variant:MODERATE:exon5/10:c.1087G>A:p.Val363Met:PF00023 [Ankyrin repeat]	BARD1:NM_000465.4:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14976G>A::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14976G>A::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24766G>A::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.1484G>A::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon4/9:n.1427G>A::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.683G>A::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation];	140757 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1];		rs2070094	0.3662	0.3840	2331,.	0.3752,0.2940,0.3662,0.3707,0.4030	-5.2630	T(0.12),T(0.13)	B(0.03),B(0.01)	0.02,0.15	0.10	0.11				0.0231	0.4387	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215632256	215632256	A	G	hom		QUAL=3056;DP=110;AF=0.55;MQM=60;SAP=18;ABP=9	BARD1	synonymous	BARD1:ENST00000260947.4:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:PF00023 [Ankyrin repeat],BARD1:ENST00000449967.2:synonymous_variant:LOW:exon5/10:c.1086T>C:p.His362=:PF00023 [Ankyrin repeat]	BARD1:NM_000465.4:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:,BARD1:NM_001282543.2:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487=:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14977T>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14977T>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24765T>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.1483T>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon4/9:n.1426T>C::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.682T>C::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation];	183704 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs2070093	0.7706	0.8169	9351,.	0.5970,0.8158,0.9535,0.8062,0.8408	-0.3720			0.01,0.18	4.57					0.0674	0.4409	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215645464	215645464	C	G	het		QUAL=1090;DP=79;AF=0.53;MQM=60;SAP=8;ABP=4	BARD1	missense	BARD1:ENST00000260947.4:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:ENST00000449967.2:missense_variant:MODERATE:exon3/10:c.702G>C:p.Arg234Ser:	BARD1:NM_000465.4:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.215+16321G>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-28185G>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+11557G>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon3/10:n.1099G>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon2/9:n.1042G>C::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.479-11428G>C::		601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation];	142769 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs2229571	0.4593	0.5522	4972,.	0.3976,0.4125,0.3645,0.6166,0.4846	-0.6010	T(0.24),T(0.19)	B(0.02),B(0.01)	0.12,0.22	9.28	0.11				-0.0023	0.2567	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	215674224	215674224	G	A	het		QUAL=8447;DP=788;AF=0.48;MQM=60;SAP=3;ABP=5	BARD1	missense,5'UTR	BARD1:ENST00000260947.4:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000449967.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-214C>T::	BARD1:NM_000465.4:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,BARD1:NM_001282545.2:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser:,BARD1:NM_001282548.2:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser:,BARD1:NM_001282549.2:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser:,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.184C>T::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon1/9:n.184C>T::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.184C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	601593 [GENE=BARD1 PHENOS=Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation];	183698 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs1048108	0.3313	0.3836	1968,.	0.2213,0.4318,0.3576,0.3775,0.4088	0.9680	T(0.13), 	B(0.01), 	0.26,0.91	17.50	0.26				0.0306	0.5029	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	220416942	220416942	G	C	hom		QUAL=1045;DP=34;AF=1.00;MQM=60;SAP=34;ABP=0	OBSL1	splice_region&intron	OBSL1:ENST00000265318.4:splice_region_variant&intron_variant:LOW:intron17/19:c.*703-4C>G::,OBSL1:ENST00000373876.1:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::,OBSL1:ENST00000404537.1:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::	OBSL1:NM_015311.3:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	194972 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs34490902	0.3876	0.4595	3370,.	0.4019,0.5464,0.4234,0.4682,0.2587	-0.7820			0.04,0.27	12.01		6.86>7.91	0.000/0.104		0.2739	0.1649	0.24	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220417266	220417266	C	T	hom		QUAL=4420;DP=146;AF=1.00;MQM=60;SAP=93;ABP=0	OBSL1	3'UTR,missense	OBSL1:ENST00000265318.4:3_prime_UTR_variant:MODIFIER:exon17/20:c.*694G>A::,OBSL1:ENST00000373876.1:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.1:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_015311.3:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:	regulatory_region_variant:promoter,TF_binding_site_variant	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	288014 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs59332477	0.3766	0.4435	3127,.	0.3735,0.5443,0.4201,0.4570,0.2527	3.5870	 ,T(0.81),T(0.33)	 ,D(1.00),D(1.00)	0.40,0.96	27.80	0.24				-0.0279	0.4104	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220419236	220419236	T	C	hom		QUAL=14216;DP=466;AF=1.00;MQM=60;SAP=515;ABP=0	OBSL1	3'UTR,synonymous	OBSL1:ENST00000265318.4:3_prime_UTR_variant:MODIFIER:exon14/20:c.*230A>G::,OBSL1:ENST00000373876.1:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:ENST00000404537.1:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:	OBSL1:NM_015311.3:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334466 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10932813		0.9967	15332,.	0.9595,0.9964,1.0000,0.9997,0.9998	-3.9420			0.04,0.36	8.87					0.0537	0.9246	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220419339	220419339	T	C	hom		QUAL=21571;DP=692;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	3'UTR,missense	OBSL1:ENST00000265318.4:3_prime_UTR_variant:MODIFIER:exon14/20:c.*127A>G::,OBSL1:ENST00000373876.1:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:ENST00000404537.1:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:	OBSL1:NM_015311.3:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334469 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10932814	0.9611	0.9873	14629,.	0.8802,0.9883,1.0000,0.9941,0.9995	0.1950	 ,T(0.61),T(0.51)	 ,B(0.00),B(0.00)	0.02,0.88	19.73	0.09				0.0628	0.9247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220420956	220420956	A	G	hom		QUAL=1388;DP=52;AF=1.00;MQM=60;SAP=91;ABP=0	OBSL1	synonymous,missense	OBSL1:ENST00000265317.5:synonymous_variant:LOW:exon5/5:c.1092T>C:p.Asp364=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318.4:missense_variant:MODERATE:exon13/20:c.3995T>C:p.Met1332Thr:,OBSL1:ENST00000373876.1:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.1:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.1:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334475 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10932816		0.9917	14831,.	0.8885,0.9929,0.9999,0.9996,0.9996	-3.7740	 ,D(0.02), , , 	 , (0.00), , , 	0.02,0.17	1.30	0.10				0.0395	0.9393	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220421417	220421417	C	G	hom		QUAL=23402;DP=732;AF=1.00;MQM=60;SAP=10;ABP=0	OBSL1	missense	OBSL1:ENST00000265317.5:missense_variant:MODERATE:exon4/5:c.792G>C:p.Glu264Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318.4:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF13895 [Immunoglobulin domain],OBSL1:ENST00000373876.1:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.1:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.1:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:		610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334483 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs1983210	0.7246	0.7384	7807,.	0.6130,0.6707,0.7101,0.7404,0.8941	0.9030	T(0.48),T(0.27),T(0.27),T(0.23),T(0.13)	B(0.08),P(0.77),P(0.77),P(0.76),D(0.95)	0.86,0.93	20.20	0.17				-0.0856	0.6619	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220422686	220422686	C	T	het		QUAL=529;DP=61;AF=0.44;MQM=60;SAP=38;ABP=5	OBSL1	missense	OBSL1:ENST00000265317.5:missense_variant:MODERATE:exon3/5:c.622G>A:p.Glu208Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318.4:missense_variant:MODERATE:exon10/20:c.3373G>A:p.Glu1125Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.1:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.1:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.1:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	193901 [benign/likely benign DISEASE=Three M syndrome 2,not specified,not provided];			rs72957510	0.0070	0.0079	1,.	0.0162,0.0019,0.0000,0.0072,0.0023	0.5010	T(0.15),T(0.23),T(0.22),T(0.50),T(0.41)	B(0.05),B(0.12),P(0.79),P(0.77),B(0.01)	0.10,0.52	18.90	0.03				-0.0453	0.0913	0	5	323	2 / 63					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220422774	220422774	A	G	hom		QUAL=23993;DP=753;AF=1.00;MQM=60;SAP=9;ABP=0	OBSL1	synonymous	OBSL1:ENST00000265317.5:synonymous_variant:LOW:exon3/5:c.534T>C:p.Pro178=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000265318.4:synonymous_variant:LOW:exon10/20:c.3285T>C:p.Pro1095=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.1:synonymous_variant:LOW:exon11/20:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.1:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.1:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:	regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334496 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs2278201	0.4191	0.4751	3573,.	0.5183,0.5484,0.4187,0.4398,0.2543	-4.6180			0.01,0.16	0.17					0.0323	0.0926	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220430203	220430203	C	T	hom		QUAL=23710;DP=741;AF=1.00;MQM=60;SAP=15;ABP=0	OBSL1	missense	OBSL1:ENST00000265318.4:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000289656.3:missense_variant:MODERATE:exon6/9:c.929G>A:p.Arg310Lys:,OBSL1:ENST00000373873.4:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373876.1:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000404537.1:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000603926.1:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:	OBSL1:NM_001173408.2:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:NM_001173431.2:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:	regulatory_region_variant:promoter_flanking_region	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	334508 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs1039898	0.7927	0.8673	11006,.	0.6290,0.8312,0.9160,0.9036,0.8350	-0.1210	T(0.67),T(0.80),T(0.80),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.03,0.65	11.32	0.05			COSV54731761	0.1636	0.3859	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	220435034	220435034	A	G	hom		QUAL=20371;DP=649;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	synonymous,intron	OBSL1:ENST00000265318.4:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+1082T>C::,OBSL1:ENST00000373873.4:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.1:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.1:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.1:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	193382 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10180675	0.7833	0.8651	10869,.	0.6051,0.8299,0.9153,0.9035,0.8331	-0.6420			0.06,0.75	13.44					0.0231	0.8817	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	220435375	220435375	G	A	het		QUAL=384;DP=19;AF=0.84;MQM=60;SAP=4;ABP=22	OBSL1	synonymous,intron	OBSL1:ENST00000265318.4:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+741C>T::,OBSL1:ENST00000373873.4:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.1:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.1:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.1:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	610991 [GENE=OBSL1 PHENOS=3-M syndrome 2,612921,Autosomal recessive];	290129 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs1061399	0.3588	0.4289	2536,.	0.1596,0.3684,0.4918,0.4562,0.4435	2.9300			0.71,0.94	12.95					0.0447	0.9102	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr3	10085536	10085536	A	G	het		QUAL=2140;DP=295;AF=0.43;MQM=60;SAP=182;ABP=17	FANCD2	synonymous	FANCD2:ENST00000287647.3:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383806.1:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383807.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.2:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_033084.5:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257065 [benign DISEASE=Fanconi anemia, complementation group D2,Fanconi anemia, complementation group A,Fanconi anemia,not specified,not provided];			rs34046352		0.1936	45,.	0.2875,0.0988,0.0387,0.0796,0.0881	-0.0020			0.00,0.07	1.01					-0.0486	0.1597	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10106532	10106532	C	T	het		QUAL=1275;DP=75;AF=0.64;MQM=60;SAP=4;ABP=16	FANCD2	missense	FANCD2:ENST00000287647.3:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383806.1:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383807.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.2:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:,FANCD2:NM_001319984.2:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:,FANCD2:NM_033084.5:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	134315 [benign DISEASE=Fanconi anemia, complementation group D2,Fanconi anemia, complementation group A,Fanconi anemia,not specified,not provided];	CM1814115 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCD2];		rs3864017		0.1875	361,.	0.2614,0.1393,0.0524,0.1409,0.1622	-0.1820	T(0.31),T(0.32),T(0.31),T(0.31)	B(0.00),B(0.00),B(0.00),B(0.00)	0.05,0.21	0.24	0.03				-0.1527	0.7078	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10138069	10138069	T	G	het		QUAL=9105;DP=785;AF=0.47;MQM=60;SAP=3;ABP=9	FANCD2,FANCD2OS	synonymous,3'UTR,intron	FANCD2:ENST00000287647.3:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000383806.1:3_prime_UTR_variant:MODIFIER:exon41/43:c.*254T>G::,FANCD2:ENST00000383807.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::	FANCD2:NM_001018115.2:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:,FANCD2:NM_033084.5:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::		613984 [GENE=FANCD2 PHENOS=Fanconi anemia,complementation group D2,227646,Autosomal recessive];	257081 [benign DISEASE=Fanconi anemia, complementation group D2,Fanconi anemia,not specified,not provided];	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2];		rs2272125	0.2422	0.2400	1189,.	0.4778,0.1816,0.0893,0.1593,0.2085	2.5830			0.21,0.96	10.97					0.0377	0.1318	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	142168331	142168331	C	T	hom		QUAL=1594;DP=49;AF=1.00;MQM=60;SAP=4;ABP=0	ATR	synonymous	ATR:ENST00000350721.4:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:PF02260 [FATC domain],ATR:ENST00000383101.3:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:PF02260 [FATC domain]	ATR:NM_001184.4:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	93669 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs1802904	0.9163	0.8883	12419,.	0.9733,0.7565,0.9333,0.8561,0.9373	1.2260			0.38,0.96	8.30					0.0243	0.9305	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a oe_syn=0.94 oe_mis=0.80 oe_lof=0.12), ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142178144	142178144	C	T	het		QUAL=1052;DP=77;AF=0.55;MQM=60;SAP=8;ABP=4	ATR	missense	ATR:ENST00000350721.4:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase],ATR:ENST00000383101.3:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase]	ATR:NM_001184.4:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:,ATR:NM_001354579.2:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	136470 [benign DISEASE=Seckel syndrome 1,not specified,not provided];	CM1010619 [CLASS=DP MUT=ALT PHEN="Acute rejection in kidney transplantation association with" GENE=ATR];		rs2229032	0.1022	0.1337	310,.	0.0795,0.0994,0.0982,0.1599,0.0957	0.0440	T(0.23),T(0.23)	B(0.00),B(0.00)	0.23,0.63	7.66	0.17				-0.029	0.1133	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142188337	142188337	A	C	het		QUAL=9936;DP=681;AF=0.56;MQM=60;SAP=4;ABP=26	ATR,RP11-383G6.3	missense,intron&non_coding_transcript	ATR:ENST00000350721.4:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:ENST00000383101.3:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:,RP11-383G6.3:ENST00000460977.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.268+2575T>G::	ATR:NM_001184.4:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:NM_001354579.2:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	158000 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];	CM1725174 [CLASS=DP MUT=ALT PHEN="Haematological traits association with" GENE=ATR];		rs28910273	0.0020	0.0032	0,.	0.0016,0.0016,0.0000,0.0056,0.0014	2.3490	T(0.06),T(0.07), 	B(0.01),B(0.01), 	0.83,0.98	15.88	0.05				0.1884	0.1512	0.03	0	258	0 / 41	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142217537	142217537	A	G	het		QUAL=3564;DP=350;AF=0.51;MQM=60;SAP=345;ABP=3	ATR	synonymous	ATR:ENST00000350721.4:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:PF02259 [FAT domain],ATR:ENST00000383101.3:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:PF02259 [FAT domain]	ATR:NM_001184.4:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	136471 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227932	0.0669	0.0922	136,.	0.0161,0.0401,0.0014,0.1098,0.1610	1.5160			0.87,0.98	10.09					0.1877	0.4608	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142277575	142277575	A	T	het		QUAL=3159;DP=274;AF=0.47;MQM=60;SAP=13;ABP=6	ATR	synonymous	ATR:ENST00000350721.4:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:ENST00000383101.3:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:	ATR:NM_001184.4:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	157965 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227930	0.5980	0.6304	6380,.	0.8003,0.4534,0.4689,0.5786,0.4321	-0.0710			0.13,0.94	9.89					0.3434	0.4804	0.34	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142281612	142281612	A	G	het		QUAL=6583;DP=530;AF=0.49;MQM=60;SAP=3;ABP=4	ATR	missense	ATR:ENST00000350721.4:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:ENST00000383101.3:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:	ATR:NM_001184.4:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:NM_001354579.2:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];	93668 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227928	0.5974	0.6296	6369,.	0.7970,0.4558,0.4701,0.5796,0.4362	1.2740	T(0.63),T(0.58)	B(0.00),B(0.00)	0.11,0.55	14.36	0.09				0.0192	0.0922	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr5	79950781	79950781	A	G	het		QUAL=420;DP=38;AF=0.47;MQM=60;SAP=27;ABP=3	MSH3,DHFR	missense&splice_region,5'UTR	MSH3:ENST00000265081.6:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,DHFR:ENST00000439211.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::	DHFR:NM_000791.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::,DHFR:NM_001290354.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-579T>C::,DHFR:NM_001290357.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-473T>C::,MSH3:NM_002439.5:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,DHFR:NR_110936.2:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.22T>C::	regulatory_region_variant:promoter	126060 [GENE=DHFR PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency,613839,Autosomal recessive],600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];	402591 [benign DISEASE=Megaloblastic anemia due to dihydrofolate reductase deficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1650697		0.8570	9631,.	0.9671,0.9134,0.8262,0.8662,0.8358	-0.4930	T(1.00), 	B(0.00), 	0.00,0.28	0.26	0.24	4.07>2.71	0.002/0.082	COSV54144023	-0.4102	0.8527	0.43	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MTRNR2L2 (inh=n/a oe_syn=0.73 oe_mis=1.01 oe_lof=n/a), MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80149981	80149981	A	G	hom		QUAL=28040;DP=903;AF=1.00;MQM=60;SAP=3;ABP=0	MSH3	missense	MSH3:ENST00000265081.6:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:PF00488 [MutS domain V]	MSH3:NM_002439.5:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:		600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];	821892 [benign DISEASE=Hereditary cancer-predisposing syndrome,none provided,not provided];			rs184967		0.8735	11896,.	0.8933,0.9129,0.9994,0.8404,0.8820	0.4030	T(1.00)	B(0.00)	0.18,0.95	14.82	0.28			COSV54143790	0.2074	0.1983	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80168937	80168937	G	A	hom		QUAL=3771;DP=114;AF=1.00;MQM=60;SAP=16;ABP=0	MSH3	missense&splice_region	MSH3:ENST00000265081.6:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:PF00488 [MutS domain V]	MSH3:NM_002439.5:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:		600887 [GENE=MSH3 PHENOS=Familial adenomatous polyposis 4,617100,Autosomal recessive/Endometrial carcinoma,somatic,608089];	822964 [benign DISEASE=Hereditary cancer-predisposing syndrome,none provided,not provided];			rs26279	0.7202	0.7294	7872,.	0.6635,0.7560,0.7469,0.7137,0.7934	1.0140	T(0.54)	B(0.04)	0.55,0.20	4.63	0.11	10.88>10.94		COSV54143807	-0.2109	0.6586	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	112162854	112162854	T	C	het		QUAL=1667;DP=183;AF=0.42;MQM=60;SAP=58;ABP=14	APC	synonymous	APC:ENST00000257430.4:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000457016.1:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000508376.2:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:	APC:NM_000038.6:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:NM_001127510.3:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:,APC:NM_001127511.3:synonymous_variant:LOW:exon10/14:c.1404T>C:p.Tyr468=:,APC:NM_001354895.2:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:NM_001354896.2:synonymous_variant:LOW:exon13/17:c.1512T>C:p.Tyr504=:,APC:NM_001354897.2:synonymous_variant:LOW:exon11/15:c.1488T>C:p.Tyr496=:,APC:NM_001354898.2:synonymous_variant:LOW:exon12/16:c.1383T>C:p.Tyr461=:,APC:NM_001354899.2:synonymous_variant:LOW:exon11/15:c.1374T>C:p.Tyr458=:,APC:NM_001354900.2:synonymous_variant:LOW:exon12/16:c.1335T>C:p.Tyr445=:,APC:NM_001354901.2:synonymous_variant:LOW:exon11/15:c.1281T>C:p.Tyr427=:,APC:NM_001354902.2:synonymous_variant:LOW:exon11/15:c.1185T>C:p.Tyr395=:,APC:NM_001354903.2:synonymous_variant:LOW:exon12/16:c.1155T>C:p.Tyr385=:,APC:NM_001354904.2:synonymous_variant:LOW:exon12/16:c.1080T>C:p.Tyr360=:,APC:NM_001354905.2:synonymous_variant:LOW:exon11/15:c.978T>C:p.Tyr326=:,APC:NM_001354906.2:synonymous_variant:LOW:exon13/17:c.609T>C:p.Tyr203=:		611731 [GENE=APC PHENOS=Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Desmoid disease,hereditary,135290,Autosomal dominant/Adenoma,periampullary,somatic,175100/Hepatoblastoma,somatic,114550/Gastric cancer,somatic,613659/Gastric adenocarcinoma and proximal polyposis of the stomach,619182,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant];	42238 [benign DISEASE=Hepatocellular carcinoma,Neoplasm of stomach,Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,Desmoid disease, hereditary,not specified,APC-Associated Polyposis Disorders,not provided];	CS1822474 [CLASS=DFP MUT=ALT PHEN="Adenomatous polyposis coli predisposition to" GENE=APC];		rs2229992		0.5844	3887,.	0.1960,0.6976,0.6734,0.5922,0.6386	1.3010			0.83,0.97	10.04				COSV57321592	0.1199	0.1616	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112164561	112164561	G	A	het		QUAL=2531;DP=179;AF=0.51;MQM=60;SAP=3;ABP=3	APC,CTC-554D6.1	synonymous,synonymous&NMD_transcript	APC:ENST00000257430.4:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000457016.1:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000508376.2:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],CTC-554D6.1:ENST00000520401.1:synonymous_variant&NMD_transcript_variant:LOW:exon3/8:c.123G>A:p.Ala41=:PF00514 [Armadillo/beta-catenin-like repeat]	APC:NM_000038.6:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:,APC:NM_001127510.3:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:,APC:NM_001127511.3:synonymous_variant:LOW:exon12/14:c.1581G>A:p.Ala527=:,APC:NM_001354895.2:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:,APC:NM_001354896.2:synonymous_variant:LOW:exon15/17:c.1689G>A:p.Ala563=:,APC:NM_001354897.2:synonymous_variant:LOW:exon13/15:c.1665G>A:p.Ala555=:,APC:NM_001354898.2:synonymous_variant:LOW:exon14/16:c.1560G>A:p.Ala520=:,APC:NM_001354899.2:synonymous_variant:LOW:exon13/15:c.1551G>A:p.Ala517=:,APC:NM_001354900.2:synonymous_variant:LOW:exon14/16:c.1512G>A:p.Ala504=:,APC:NM_001354901.2:synonymous_variant:LOW:exon13/15:c.1458G>A:p.Ala486=:,APC:NM_001354902.2:synonymous_variant:LOW:exon13/15:c.1362G>A:p.Ala454=:,APC:NM_001354903.2:synonymous_variant:LOW:exon14/16:c.1332G>A:p.Ala444=:,APC:NM_001354904.2:synonymous_variant:LOW:exon14/16:c.1257G>A:p.Ala419=:,APC:NM_001354905.2:synonymous_variant:LOW:exon13/15:c.1155G>A:p.Ala385=:,APC:NM_001354906.2:synonymous_variant:LOW:exon15/17:c.786G>A:p.Ala262=:		611731 [GENE=APC PHENOS=Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Desmoid disease,hereditary,135290,Autosomal dominant/Adenoma,periampullary,somatic,175100/Hepatoblastoma,somatic,114550/Gastric cancer,somatic,613659/Gastric adenocarcinoma and proximal polyposis of the stomach,619182,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant];	42239 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs351771	0.6661	0.6492	5541,.	0.5317,0.7330,0.8218,0.6187,0.7136	1.6080			0.26,0.97	12.40				COSV57321606	-0.0108	0.8845	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112175770	112175770	G	A	het		QUAL=5170;DP=423;AF=0.49;MQM=60;SAP=3;ABP=3	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430.4:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000457016.1:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000508376.2:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],CTC-554D6.1:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11101G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.4425G>A:p.Thr1475=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.4533G>A:p.Thr1511=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.4509G>A:p.Thr1503=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.4404G>A:p.Thr1468=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.4395G>A:p.Thr1465=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.4356G>A:p.Thr1452=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.4302G>A:p.Thr1434=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4206G>A:p.Thr1402=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4176G>A:p.Thr1392=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4101G>A:p.Thr1367=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.3999G>A:p.Thr1333=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.3630G>A:p.Thr1210=:		611731 [GENE=APC PHENOS=Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Desmoid disease,hereditary,135290,Autosomal dominant/Adenoma,periampullary,somatic,175100/Hepatoblastoma,somatic,114550/Gastric cancer,somatic,613659/Gastric adenocarcinoma and proximal polyposis of the stomach,619182,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant];	42242 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs41115	0.6655	0.6497	5534,.	0.5328,0.7339,0.8216,0.6188,0.7128	0.0930			0.46,0.90	8.19				COSV57321403,COSV57381675	-0.0042	0.8999	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112176325	112176325	G	A	het		QUAL=233;DP=26;AF=0.50;MQM=60;SAP=31;ABP=3	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430.4:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:ENST00000457016.1:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:ENST00000508376.2:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:,CTC-554D6.1:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11656G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.4980G>A:p.Gly1660=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5088G>A:p.Gly1696=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5064G>A:p.Gly1688=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.4959G>A:p.Gly1653=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.4950G>A:p.Gly1650=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.4911G>A:p.Gly1637=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.4857G>A:p.Gly1619=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4761G>A:p.Gly1587=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4731G>A:p.Gly1577=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4656G>A:p.Gly1552=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.4554G>A:p.Gly1518=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.4185G>A:p.Gly1395=:		611731 [GENE=APC PHENOS=Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Desmoid disease,hereditary,135290,Autosomal dominant/Adenoma,periampullary,somatic,175100/Hepatoblastoma,somatic,114550/Gastric cancer,somatic,613659/Gastric adenocarcinoma and proximal polyposis of the stomach,619182,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant];	42243 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs42427	0.6667	0.6524	5580,.	0.5353,0.7363,0.8218,0.6235,0.7127	0.3110			0.21,0.40	4.52				COSV57321627	0.0138	0.9001	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112176559	112176559	T	G	het		QUAL=3249;DP=261;AF=0.49;MQM=60;SAP=4;ABP=3	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430.4:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:ENST00000457016.1:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:ENST00000508376.2:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:,CTC-554D6.1:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11890T>G::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.5214T>G:p.Ser1738=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5322T>G:p.Ser1774=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5298T>G:p.Ser1766=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.5193T>G:p.Ser1731=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.5184T>G:p.Ser1728=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.5145T>G:p.Ser1715=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.5091T>G:p.Ser1697=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4995T>G:p.Ser1665=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4965T>G:p.Ser1655=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4890T>G:p.Ser1630=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.4788T>G:p.Ser1596=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.4419T>G:p.Ser1473=:		611731 [GENE=APC PHENOS=Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Desmoid disease,hereditary,135290,Autosomal dominant/Adenoma,periampullary,somatic,175100/Hepatoblastoma,somatic,114550/Gastric cancer,somatic,613659/Gastric adenocarcinoma and proximal polyposis of the stomach,619182,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant];	42245 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs866006		0.6513	5567,.	0.5340,0.7343,0.8213,0.6209,0.7135	0.9850			0.72,0.25	0.05				COSV57321636,COSV57325918	0.0043	0.9	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112176756	112176756	T	A	het		QUAL=4290;DP=381;AF=0.45;MQM=60;SAP=8;ABP=11	APC,CTC-554D6.1	missense,intron&NMD_transcript	APC:ENST00000257430.4:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:ENST00000457016.1:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:ENST00000508376.2:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:,CTC-554D6.1:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+12087T>A::	APC:NM_000038.6:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:NM_001127510.3:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:,APC:NM_001127511.3:missense_variant:MODERATE:exon14/14:c.5411T>A:p.Val1804Asp:,APC:NM_001354895.2:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:NM_001354896.2:missense_variant:MODERATE:exon17/17:c.5519T>A:p.Val1840Asp:,APC:NM_001354897.2:missense_variant:MODERATE:exon15/15:c.5495T>A:p.Val1832Asp:,APC:NM_001354898.2:missense_variant:MODERATE:exon16/16:c.5390T>A:p.Val1797Asp:,APC:NM_001354899.2:missense_variant:MODERATE:exon15/15:c.5381T>A:p.Val1794Asp:,APC:NM_001354900.2:missense_variant:MODERATE:exon16/16:c.5342T>A:p.Val1781Asp:,APC:NM_001354901.2:missense_variant:MODERATE:exon15/15:c.5288T>A:p.Val1763Asp:,APC:NM_001354902.2:missense_variant:MODERATE:exon15/15:c.5192T>A:p.Val1731Asp:,APC:NM_001354903.2:missense_variant:MODERATE:exon16/16:c.5162T>A:p.Val1721Asp:,APC:NM_001354904.2:missense_variant:MODERATE:exon16/16:c.5087T>A:p.Val1696Asp:,APC:NM_001354905.2:missense_variant:MODERATE:exon15/15:c.4985T>A:p.Val1662Asp:,APC:NM_001354906.2:missense_variant:MODERATE:exon17/17:c.4616T>A:p.Val1539Asp:		611731 [GENE=APC PHENOS=Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Desmoid disease,hereditary,135290,Autosomal dominant/Adenoma,periampullary,somatic,175100/Hepatoblastoma,somatic,114550/Gastric cancer,somatic,613659/Gastric adenocarcinoma and proximal polyposis of the stomach,619182,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant];	21030 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs459552		0.8094	10459,.	0.9587,0.8269,0.9029,0.7706,0.7820	3.6530	T(0.50),T(0.50),T(0.50), 	B(0.00),B(0.00),B(0.00), 	0.05,0.95	18.00	0.19			COSV57321643	0.0053	0.9	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112177171	112177171	G	A	het		QUAL=9917;DP=812;AF=0.49;MQM=60;SAP=4;ABP=5	APC,CTC-554D6.1	synonymous,intron&NMD_transcript	APC:ENST00000257430.4:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000457016.1:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000508376.2:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],CTC-554D6.1:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+12502G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.5826G>A:p.Pro1942=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5934G>A:p.Pro1978=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5910G>A:p.Pro1970=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.5805G>A:p.Pro1935=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.5796G>A:p.Pro1932=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.5757G>A:p.Pro1919=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.5703G>A:p.Pro1901=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.5607G>A:p.Pro1869=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.5577G>A:p.Pro1859=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.5502G>A:p.Pro1834=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.5400G>A:p.Pro1800=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.5031G>A:p.Pro1677=:		611731 [GENE=APC PHENOS=Colorectal cancer,somatic,114500/Brain tumor-polyposis syndrome 2,175100,Autosomal dominant/Desmoid disease,hereditary,135290,Autosomal dominant/Adenoma,periampullary,somatic,175100/Hepatoblastoma,somatic,114550/Gastric cancer,somatic,613659/Gastric adenocarcinoma and proximal polyposis of the stomach,619182,Autosomal dominant/Gardner syndrome,175100,Autosomal dominant/Adenomatous polyposis coli,175100,Autosomal dominant];	42247 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs465899	0.6665	0.6497	5574,.	0.5367,0.7336,0.8217,0.6188,0.7122	-0.1780			0.23,0.91	8.95				COSV57321652	-0.0026	0.8999	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	131925483	131925483	G	C	het		QUAL=814;DP=67;AF=0.49;MQM=60;SAP=3;ABP=3	RAD50	missense	RAD50:ENST00000265335.6:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:,RAD50:ENST00000378823.3:missense_variant:MODERATE:exon9/25:c.989G>C:p.Gly330Ala:	RAD50:NM_005732.4:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:		604040 [GENE=RAD50 PHENOS=Nijmegen breakage syndrome-like disorder,613078,Autosomal recessive];	216618 [uncertain significance DISEASE=Hereditary cancer-predisposing syndrome];			rs55653181	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	6.3330	T(0.20),T(0.21)	B(0.19),B(0.19)	0.98,0.99	22.60	0.26				-0.0234	0.5698	0	0	33	0 / 3					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr6	35423662	35423662	A	C	het		QUAL=871;DP=98;AF=0.40;MQM=60;SAP=3;ABP=12	FANCE	synonymous	FANCE:ENST00000229769.2:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:	FANCE:NM_021922.3:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:		613976 [GENE=FANCE PHENOS=Fanconi anemia,complementation group E,600901,Autosomal recessive];	261435 [benign DISEASE=Fanconi anemia, complementation group E,not specified,not provided];			rs4713867		0.7433	8772,.	0.8720,0.8209,0.6819,0.6734,0.7478	-1.1480			0.00,0.14	1.72					-0.0146	0.3199	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr7	6026775	6026775	T	C	hom		QUAL=524;DP=21;AF=1.00;MQM=60;SAP=49;ABP=0	PMS2	missense,intron	PMS2:ENST00000265849.7:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000382321.4:intron_variant:MODIFIER:intron7/10:c.804-4153A>G::,PMS2:ENST00000406569.3:missense_variant:MODERATE:exon11/12:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000441476.2:missense_variant:MODERATE:exon8/12:c.1303A>G:p.Lys435Glu:	PMS2:NM_000535.7:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:NM_001322003.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322004.2:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322005.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322006.2:missense_variant:MODERATE:exon10/14:c.1465A>G:p.Lys489Glu:,PMS2:NM_001322007.1:missense_variant:MODERATE:exon10/14:c.1303A>G:p.Lys435Glu:,PMS2:NM_001322008.2:missense_variant:MODERATE:exon9/13:c.1303A>G:p.Lys435Glu:,PMS2:NM_001322009.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322010.2:missense_variant:MODERATE:exon9/13:c.1060A>G:p.Lys354Glu:,PMS2:NM_001322011.2:missense_variant:MODERATE:exon11/15:c.688A>G:p.Lys230Glu:,PMS2:NM_001322012.2:missense_variant:MODERATE:exon11/15:c.688A>G:p.Lys230Glu:,PMS2:NM_001322013.2:missense_variant:MODERATE:exon10/14:c.1048A>G:p.Lys350Glu:,PMS2:NM_001322014.2:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:NM_001322015.2:missense_variant:MODERATE:exon11/15:c.1312A>G:p.Lys438Glu:,PMS2:NR_136154.1:non_coding_transcript_exon_variant:MODIFIER:exon11/15:n.1708A>G::		600259 [GENE=PMS2 PHENOS=Colorectal cancer,hereditary nonpolyposis,type 4,614337/Mismatch repair cancer syndrome 4,619101,Autosomal recessive];	135065 [benign DISEASE=Hereditary nonpolyposis colorectal cancer type 4,Hereditary nonpolyposis colorectal neoplasms,not specified];			rs2228006	0.8832	0.8724	11970,.	0.9247,0.6690,0.9212,0.8498,0.8953	1.4430	T(1.00), ,T(1.00),T(1.00)	B(0.00), ,B(0.00),B(0.00)	0.00,0.13	10.11	0.16				0.0514	0.8612	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	6036980	6036980	G	C	hom		QUAL=748;DP=24;AF=1.00;MQM=60;SAP=3;ABP=0	PMS2	synonymous	PMS2:ENST00000265849.7:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000382321.4:synonymous_variant:LOW:exon7/11:c.780C>G:p.Ser260=:,PMS2:ENST00000406569.3:synonymous_variant:LOW:exon7/12:c.780C>G:p.Ser260=:,PMS2:ENST00000441476.2:synonymous_variant:LOW:exon4/12:c.462C>G:p.Ser154=:	PMS2:NM_000535.7:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:NM_001322003.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322004.2:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:NM_001322005.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322006.2:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:NM_001322007.1:synonymous_variant:LOW:exon6/14:c.462C>G:p.Ser154=:,PMS2:NM_001322008.2:synonymous_variant:LOW:exon5/13:c.462C>G:p.Ser154=:,PMS2:NM_001322009.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322010.2:synonymous_variant:LOW:exon6/13:c.375C>G:p.Ser125=:,PMS2:NM_001322011.2:5_prime_UTR_variant:MODIFIER:exon7/15:c.-154C>G::,PMS2:NM_001322012.2:5_prime_UTR_variant:MODIFIER:exon7/15:c.-154C>G::,PMS2:NM_001322013.2:synonymous_variant:LOW:exon6/14:c.207C>G:p.Ser69=:,PMS2:NM_001322014.2:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:NM_001322015.2:synonymous_variant:LOW:exon7/15:c.471C>G:p.Ser157=:,PMS2:NR_136154.1:non_coding_transcript_exon_variant:MODIFIER:exon7/15:n.867C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	600259 [GENE=PMS2 PHENOS=Colorectal cancer,hereditary nonpolyposis,type 4,614337/Mismatch repair cancer syndrome 4,619101,Autosomal recessive];	36693 [benign DISEASE=Endometrial carcinoma,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 4,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,none provided,not provided];			rs1805319		0.8206	10471,.	0.8425,0.6511,0.9207,0.8166,0.8173	-2.6950			0.03,0.07	0.17					0.1633	0.368	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	6037057	6037057	-	A	het	low_conf_region	QUAL=230;DP=27;AF=0.44;MQM=60;SAP=6;ABP=4	PMS2	splice_region&intron	PMS2:ENST00000265849.7:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000382321.4:splice_region_variant&intron_variant:LOW:intron6/10:c.706-4dup::,PMS2:ENST00000406569.3:splice_region_variant&intron_variant:LOW:intron6/11:c.706-4dup::,PMS2:ENST00000441476.2:splice_region_variant&intron_variant:LOW:intron3/11:c.388-4dup::	PMS2:NM_000535.7:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:NM_001322003.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322004.2:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:NM_001322005.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322006.2:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:NM_001322007.1:splice_region_variant&intron_variant:LOW:intron5/13:c.388-4dup::,PMS2:NM_001322008.2:splice_region_variant&intron_variant:LOW:intron4/12:c.388-4dup::,PMS2:NM_001322009.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322010.2:splice_region_variant&intron_variant:LOW:intron5/12:c.301-4dup::,PMS2:NM_001322011.2:splice_region_variant&intron_variant:LOW:intron6/14:c.-228-4dup::,PMS2:NM_001322012.2:splice_region_variant&intron_variant:LOW:intron6/14:c.-228-4dup::,PMS2:NM_001322013.2:splice_region_variant&intron_variant:LOW:intron5/13:c.133-4dup::,PMS2:NM_001322014.2:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:NM_001322015.2:splice_region_variant&intron_variant:LOW:intron6/14:c.397-4dup::,PMS2:NR_136154.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron6/14:n.793-4dup::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	600259 [GENE=PMS2 PHENOS=Colorectal cancer,hereditary nonpolyposis,type 4,614337/Mismatch repair cancer syndrome 4,619101,Autosomal recessive];	198429 [likely benign(replaced by megSAP based on classifications:6x1,3x2,1x3) DISEASE=Lynch syndrome,Lynch syndrome I,Hereditary nonpolyposis colorectal cancer type 4,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];		(A)n (Simple_repeat)	rs60794673		0.0962	71,.	0.0783,0.0866,0.0270,0.0766,0.0460					10.17					-0.0729	0.2591	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	128846328	128846328	G	C	hom		QUAL=28443;DP=908;AF=1.00;MQM=60;SAP=3;ABP=0	SMO	synonymous	SMO:ENST00000249373.3:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:PF01534 [Frizzled/Smoothened family membrane region]	SMO:NM_005631.5:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:		601500 [GENE=SMO PHENOS=Pallister-Hall-like syndrome,241800,Autosomal recessive/Basal cell carcinoma,somatic,605462/Curry-Jones syndrome,somatic mosaic,601707];	403462 [benign DISEASE=not specified,not provided];			rs2228617		0.7981	9942,.	0.6878,0.7170,0.7677,0.8413,0.7658	1.1300			0.42,0.97	11.65					0.0729	0.0701	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	142460313	142460313	T	C	hom		QUAL=4964;DP=164;AF=1.00;MQM=60;SAP=13;ABP=0	PRSS1	synonymous	PRSS1:ENST00000311737.7:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:PF00089 [Trypsin],PRSS1:ENST00000486171.1:synonymous_variant:LOW:exon5/6:c.528T>C:p.Asp176=:PF00089 [Trypsin]	PRSS1:NM_002769.5:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:		276000 [GENE=PRSS1 PHENOS=Pancreatitis,hereditary,167800,Autosomal dominant];	239391 [benign/likely benign DISEASE=Hereditary pancreatitis,Inborn genetic diseases,not specified];			rs6666	0.3966	0.4105	995,.	0.3600,0.4294,0.2078,0.4259,0.2607	-4.3320			0.02,0.08	0.11					0.0154	0.5151	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142460865	142460865	T	C	hom		QUAL=10156;DP=357;AF=1.00;MQM=60;SAP=411;ABP=0	PRSS1	synonymous	PRSS1:ENST00000311737.7:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:,PRSS1:ENST00000486171.1:synonymous_variant:LOW:exon6/6:c.780T>C:p.Asn260=:	PRSS1:NM_002769.5:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:		276000 [GENE=PRSS1 PHENOS=Pancreatitis,hereditary,167800,Autosomal dominant];	258803 [benign/likely benign DISEASE=Hereditary pancreatitis,Inborn genetic diseases,not specified];			rs6667	0.3938	0.5221	4349,.	0.4323,0.5609,0.2287,0.5783,0.3051	0.2230			0.01,0.80	5.12					0.354	0.9275	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AR+AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr8	90958422	90958422	T	C	het		QUAL=584;DP=47;AF=0.55;MQM=60;SAP=11;ABP=4	NBN	synonymous	NBN:ENST00000265433.3:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:,NBN:ENST00000409330.1:synonymous_variant:LOW:exon13/16:c.1770A>G:p.Pro590=:	NBN:NM_001024688.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:NM_002485.4:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Aplastic anemia,609135/Nijmegen breakage syndrome,251260,Autosomal recessive];	183696 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1061302	0.3528	0.3467	1606,.	0.2298,0.3492,0.4561,0.3250,0.4285	-0.8170			0.06,0.19	0.63					0.066	0.2521	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90958530	90958530	T	C	het		QUAL=380;DP=35;AF=0.46;MQM=60;SAP=12;ABP=4	NBN	splice_region&intron	NBN:ENST00000265433.3:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::,NBN:ENST00000409330.1:splice_region_variant&intron_variant:LOW:intron12/15:c.1669-7A>G::	NBN:NM_001024688.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:NM_002485.4:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Aplastic anemia,609135/Nijmegen breakage syndrome,251260,Autosomal recessive];	258768 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs2308962	0.3790	0.3535	1805,.	0.3186,0.3539,0.4561,0.3253,0.4278	-1.8420			0.02,0.10	0.08		3.91>3.28	0.000/0.036		0.0539	0.222	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90967711	90967711	A	G	het		QUAL=349;DP=37;AF=0.43;MQM=60;SAP=4;ABP=4	NBN	synonymous	NBN:ENST00000265433.3:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:,NBN:ENST00000409330.1:synonymous_variant:LOW:exon10/16:c.951T>C:p.Asp317=:	NBN:NM_001024688.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:NM_002485.4:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Aplastic anemia,609135/Nijmegen breakage syndrome,251260,Autosomal recessive];	183701 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];			rs709816	0.6086	0.5112	4568,.	0.7781,0.5773,0.6480,0.3625,0.5115	0.0420			0.03,0.15	0.42					0.0447	0.2201	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90990479	90990479	C	G	het		QUAL=10738;DP=828;AF=0.50;MQM=60;SAP=3;ABP=3	NBN	missense	NBN:ENST00000265433.3:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:,NBN:ENST00000409330.1:missense_variant:MODERATE:exon5/16:c.307G>C:p.Glu103Gln:	NBN:NM_001024688.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:NM_002485.4:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:		602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Aplastic anemia,609135/Nijmegen breakage syndrome,251260,Autosomal recessive];	134876 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN];		rs1805794	0.3570	0.3470	1628,.	0.2363,0.3494,0.4562,0.3246,0.4281	2.1330	T(1.00),T(1.00)	B(0.00),B(0.00)	0.09,0.94	14.87	0.10			COSV55372457,COSV55375647	0.001	0.4491	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	90995019	90995019	C	T	het		QUAL=99;DP=19;AF=0.37;MQM=60;SAP=18;ABP=6	NBN	synonymous,5'UTR	NBN:ENST00000265433.3:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000409330.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-145G>A::	NBN:NM_001024688.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:NM_002485.4:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:	regulatory_region_variant:promoter	602667 [GENE=NBN PHENOS=Leukemia,acute lymphoblastic,613065/Aplastic anemia,609135/Nijmegen breakage syndrome,251260,Autosomal recessive];	183697 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1063045	0.3792	0.3535	1792,.	0.3184,0.3540,0.4563,0.3253,0.4283	-0.2470			0.10,0.85	12.20					-0.2882	0.9483	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr9	17273878	17273878	A	G	het		QUAL=1145;DP=64;AF=0.72;MQM=60;SAP=4;ABP=30	CNTLN	intron	CNTLN:ENST00000262360.5:intron_variant:MODIFIER:intron6/25:c.987+10A>G::,CNTLN:ENST00000380641.4:intron_variant:MODIFIER:intron6/6:c.983+14A>G::,CNTLN:ENST00000380647.3:intron_variant:MODIFIER:intron6/25:c.983+14A>G::,CNTLN:ENST00000425824.1:intron_variant:MODIFIER:intron6/25:c.987+10A>G::	CNTLN:NM_001114395.3:intron_variant:MODIFIER:intron6/6:c.983+14A>G::,CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron6/25:c.983+14A>G::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron6/25:c.983+14A>G::						rs12376938	0.2258	0.2498	897,.	0.1713,0.1941,0.0717,0.2631,0.3574	-1.6410			0.00,0.08	5.76					-0.1456	0.7194	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17342383	17342383	C	T	hom		QUAL=983;DP=30;AF=1.00;MQM=60;SAP=13;ABP=0	CNTLN	synonymous	CNTLN:ENST00000262360.5:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:ENST00000380647.3:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:ENST00000425824.1:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:						rs1442527	0.9495	0.9887	14455,.	0.8435,0.9919,1.0000,0.9995,0.9998	2.3280			0.13,0.94	8.10					-0.0475	0.3743	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394536	17394536	C	T	hom		QUAL=1783;DP=56;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	missense	CNTLN:ENST00000262360.5:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:ENST00000380647.3:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:ENST00000425824.1:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:	CNTLN:NM_001365029.1:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:NM_017738.4:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:						rs7035276		0.8300	10710,.	0.6917,0.7734,0.8094,0.8725,0.7405	0.3250	T(0.27),T(0.27),T(0.27)	B(0.00),B(0.00),B(0.00)	0.11,0.67	13.60	0.06				-0.0335	0.0775	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394996	17394996	T	C	hom		QUAL=3143;DP=98;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	synonymous	CNTLN:ENST00000262360.5:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:ENST00000380647.3:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:ENST00000425824.1:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	regulatory_region_variant:promoter_flanking_region					rs3739489	0.8411	0.8779	12081,.	0.7731,0.7920,0.8121,0.9165,0.8706	0.6140			0.30,0.96	8.33					0.0187	0.0783	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409366	17409366	G	A	hom		QUAL=12154;DP=384;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	synonymous	CNTLN:ENST00000262360.5:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:,CNTLN:ENST00000380647.3:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:,CNTLN:ENST00000425824.1:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon16/26:c.2688G>A:p.Thr896=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:						rs2780211		0.8742	12056,.	0.7732,0.7924,0.8113,0.9133,0.8500	0.9030			0.01,0.65	8.89					-0.1125	0.3485	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457513	17457513	A	-	hom	low_conf_region	QUAL=104;DP=4;AF=1.00;MQM=60;SAP=12;ABP=0	CNTLN	intron	CNTLN:ENST00000262360.5:intron_variant:MODIFIER:intron18/25:c.3115-2del::,CNTLN:ENST00000380647.3:intron_variant:MODIFIER:intron18/25:c.3115-2del::,CNTLN:ENST00000425824.1:intron_variant:MODIFIER:intron18/25:c.3115-2del::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron18/25:c.3112-2del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron18/25:c.3115-2del::					(TATATT)n (Simple_repeat)	rs35399020		0.8540	10171,.	0.5934,0.7533,0.6981,0.9105,0.7931	0.1540				0.67				COSV52086669	-0.0709	0.3299	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	21971137	21971137	T	G	het		QUAL=264;DP=53;AF=0.45;MQM=60;SAP=55;ABP=4	CDKN2A,RP11-145E5.5	missense,synonymous,intron&NMD_transcript	CDKN2A:ENST00000304494.5:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000361570.3:synonymous_variant:LOW:exon2/3:c.387A>C:p.Arg129=:,RP11-145E5.5:ENST00000404796.2:intron_variant&NMD_transcript_variant:MODIFIER:intron4/5:c.348-58295T>G::,CDKN2A:ENST00000446177.1:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000479692.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000494262.1:missense_variant:MODERATE:exon3/4:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000497750.1:missense_variant:MODERATE:exon2/2:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000498124.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000498628.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000530628.2:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:ENST00000578845.2:missense_variant:MODERATE:exon1/2:c.68A>C:p.Asp23Ala:PF12796 [Ankyrin repeats (3 copies)],CDKN2A:ENST00000579122.1:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000579755.1:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:	CDKN2A:NM_000077.4:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:NM_001195132.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:,CDKN2A:NM_001363763.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:NM_058195.3:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:NM_058197.4:3_prime_UTR_variant:MODIFIER:exon2/3:c.*144A>C::		600160 [GENE=CDKN2A PHENOS=Melanoma and neural system tumor syndrome,155755,Autosomal dominant/Melanoma,cutaneous malignant,2,155601,Autosomal dominant/Melanoma-pancreatic cancer syndrome,606719,Autosomal dominant];	802463 [uncertain significance DISEASE=Melanoma-pancreatic cancer syndrome];	CM165602 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=CDKN2A];		rs200429615		0.0013		0.0007,0.0005,0.0000,0.0019,0.0007	5.3760	D(0.00), , ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), ,D(0.00),D(0.00), 	D(1.00), , ,D(1.00),D(1.00),D(1.00),D(1.00),D(1.00),D(1.00), ,D(1.00),P(0.87), 	0.97,0.98	29.20	0.88			COSV58684939,COSV58689077	-0.0702	0.8399	0.01	4	214	4 / 214	1	"[1] old entry - no details available"			CDKN2A-DT (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=n/a), CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	35074917	35074917	T	C	hom		QUAL=3127;DP=99;AF=1.00;MQM=60;SAP=6;ABP=0	FANCG	splice_region&intron	FANCG:ENST00000378643.3:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::	FANCG:NM_004629.1:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::		601023 [GENE=VCP PHENOS=Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,613954/Charcot-Marie-Tooth disease,type 2Y,616687,Autosomal dominant/Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1,167320,Autosomal dominant],602956 [GENE=FANCG PHENOS=Fanconi anemia,complementation group G,614082,Autosomal recessive];	259477 [benign DISEASE=Fanconi anemia, complementation group G,Fanconi anemia,not specified,Amyotrophic Lateral Sclerosis, Dominant,Inclusion Body Myopathy, Dominant,not provided];			rs587118	0.2202	0.4017	2719,.	0.0803,0.5007,0.0032,0.4999,0.2614	0.2340			0.13,0.60	13.19			0.000/0.002		-0.673	0.6888	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	98209594	98209594	G	A	het		QUAL=1180;DP=71;AF=0.66;MQM=60;SAP=4;ABP=19	PTCH1	missense	PTCH1:ENST00000331920.6:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:ENST00000375274.2:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:ENST00000418258.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000421141.1:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000429896.2:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000430669.2:missense_variant:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu:,PTCH1:ENST00000437951.1:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu:	PTCH1:NM_000264.5:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:NM_001083602.2:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu:,PTCH1:NM_001083603.2:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:NM_001083604.2:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083605.2:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083606.3:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083607.2:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001354918.2:missense_variant:MODERATE:exon22/23:c.3788C>T:p.Pro1263Leu:,PTCH1:NR_149061.2:non_coding_transcript_exon_variant:MODIFIER:exon23/24:n.4683C>T::		601309 [GENE=PTCH1 PHENOS=Basal cell carcinoma,somatic,605462/Holoprosencephaly 7,610828,Autosomal dominant/Basal cell nevus syndrome,109400,Autosomal dominant];	41663 [benign DISEASE=Gorlin syndrome,Holoprosencephaly 7,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];			rs357564	0.3968	0.3892	1900,.	0.2327,0.4872,0.5627,0.3388,0.4468	9.4090	D(0.01),D(0.01),D(0.01),D(0.01),D(0.01),D(0.01),D(0.01)	B(0.44),P(0.71),B(0.44),B(0.44),B(0.44),P(0.65),P(0.65)	1.00,0.99	24.60	0.44				0.0236	0.9089	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	98232224	98232224	A	-	het		QUAL=546;DP=59;AF=0.54;MQM=60;SAP=72;ABP=4	PTCH1	intron	PTCH1:ENST00000331920.6:intron_variant:MODIFIER:intron12/23:c.1729-11del::,PTCH1:ENST00000375274.2:intron_variant:MODIFIER:intron12/23:c.1726-11del::,PTCH1:ENST00000418258.1:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:ENST00000421141.1:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:ENST00000429896.2:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:ENST00000430669.2:intron_variant:MODIFIER:intron12/22:c.1531-11del::,PTCH1:ENST00000437951.1:intron_variant:MODIFIER:intron12/23:c.1531-11del::	PTCH1:NM_000264.5:intron_variant:MODIFIER:intron12/23:c.1729-11del::,PTCH1:NM_001083602.2:intron_variant:MODIFIER:intron12/23:c.1531-11del::,PTCH1:NM_001083603.2:intron_variant:MODIFIER:intron12/23:c.1726-11del::,PTCH1:NM_001083604.2:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083605.2:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083606.3:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083607.2:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001354918.2:intron_variant:MODIFIER:intron11/22:c.1573-11del::,LOC100507346:NR_038982.1:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.1887del::,PTCH1:NR_149061.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/23:n.2634-11del::		601309 [GENE=PTCH1 PHENOS=Basal cell carcinoma,somatic,605462/Holoprosencephaly 7,610828,Autosomal dominant/Basal cell nevus syndrome,109400,Autosomal dominant];	1290901 [benign DISEASE=not provided];			rs779000277		0.0011	0,.	0.0001,0.0007,0.0000,0.0020,0.0000	0.6250				0.46				COSV59495096	-0.2837	0.3034	0.01	0	84	0 / 11					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr10	43595968	43595968	A	G	hom		QUAL=16186;DP=520;AF=1.00;MQM=60;SAP=4;ABP=0	RET	synonymous	RET:ENST00000340058.5:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:,RET:ENST00000355710.3:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:	RET:NM_020630.5:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:,RET:NM_020975.6:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:		164761 [GENE=RET PHENOS=Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant/Multiple endocrine neoplasia IIB,162300,Autosomal dominant];	167589 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified,not provided];			rs1800858		0.7725	9544,.	0.9530,0.7589,0.5513,0.7401,0.7290	-2.5110			0.01,0.17	1.17					0.0061	0.2502	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43613843	43613843	G	T	hom		QUAL=37763;DP=1156;AF=1.00;MQM=60;SAP=3;ABP=0	RET	synonymous	RET:ENST00000340058.5:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine kinase],RET:ENST00000355710.3:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine kinase]	RET:NM_001355216.1:synonymous_variant:LOW:exon10/16:c.1545G>T:p.Leu515=:,RET:NM_020630.5:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:,RET:NM_020975.6:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:		164761 [GENE=RET PHENOS=Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant/Multiple endocrine neoplasia IIB,162300,Autosomal dominant];	167590 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified,not provided];			rs1800861		0.7798	9644,.	0.8846,0.7707,0.5057,0.7688,0.6426	1.2300			0.79,0.94	10.76					0.0197	0.2444	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AR+AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	88635779	88635779	C	A	het		QUAL=850;DP=71;AF=0.56;MQM=52;SAP=4;ABP=5	BMPR1A	missense	BMPR1A:ENST00000372037.3:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:	BMPR1A:NM_004329.2:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:		601299 [GENE=BMPR1A PHENOS=Polyposis syndrome,hereditary mixed,2,610069/Polyposis,juvenile intestinal,174900,Autosomal dominant];	41782 [benign DISEASE=Generalized juvenile polyposis/juvenile polyposis coli,Hereditary cancer-predisposing syndrome,Juvenile polyposis syndrome,not specified,none provided,not provided];			rs11528010	0.4998	0.4123	3213,.	0.6679,0.3900,0.7182,0.2583,0.3004	3.7690	T(1.00)	B(0.00)	0.02,0.92	14.41	0.21			COSV64406247	0.0009	0.15	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	104264107	104264107	C	T	hom		QUAL=9982;DP=411;AF=1.00;MQM=60;SAP=895;ABP=0	SUFU	intron	SUFU:ENST00000369899.2:intron_variant:MODIFIER:intron1/10:c.182+16C>T::,SUFU:ENST00000369902.3:intron_variant:MODIFIER:intron1/11:c.182+16C>T::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron1/9:c.182+16C>T::	SUFU:NM_001178133.2:intron_variant:MODIFIER:intron1/10:c.182+16C>T::,SUFU:NM_016169.3:intron_variant:MODIFIER:intron1/11:c.182+16C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607035 [GENE=SUFU PHENOS=Meningioma,familial,susceptibility to,607174,Autosomal dominant/Joubert syndrome 32,617757,Autosomal recessive/Medulloblastoma,desmoplastic,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Basal cell nevus syndrome,109400,Autosomal dominant];	260689 [benign DISEASE=not specified,not provided];			rs2274351	0.3962	0.4757	3507,.	0.3131,0.2994,0.3222,0.5481,0.4885	-0.2610			0.10,0.79	16.75					0.0071	0.5444	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTR1A (inh=n/a oe_syn=0.79 oe_mis=0.44 oe_lof=0.13), SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	104387019	104387019	T	C	het		QUAL=14824;DP=1197;AF=0.49;MQM=60;SAP=4;ABP=5	SUFU	intron	SUFU:ENST00000369902.3:intron_variant:MODIFIER:intron11/11:c.1365+19T>C::	SUFU:NM_016169.3:intron_variant:MODIFIER:intron11/11:c.1365+19T>C::		607035 [GENE=SUFU PHENOS=Meningioma,familial,susceptibility to,607174,Autosomal dominant/Joubert syndrome 32,617757,Autosomal recessive/Medulloblastoma,desmoplastic,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Basal cell nevus syndrome,109400,Autosomal dominant];	260688 [benign DISEASE=not specified,not provided];			rs12414407	0.7196	0.6877	7422,.	0.7545,0.5777,0.7448,0.6474,0.7144	0.2210			0.01,0.32	11.26					0.0498	0.4218	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	104389932	104389932	T	G	hom		QUAL=59563;DP=1886;AF=1.00;MQM=60;SAP=4;ABP=0	SUFU	3'UTR	SUFU:ENST00000369902.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::	SUFU:NM_016169.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::		607035 [GENE=SUFU PHENOS=Meningioma,familial,susceptibility to,607174,Autosomal dominant/Joubert syndrome 32,617757,Autosomal recessive/Medulloblastoma,desmoplastic,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Basal cell nevus syndrome,109400,Autosomal dominant];	1175161 [benign DISEASE=not specified];			rs4917980		0.9995	15632,.	0.9934,0.9994,1.0000,0.9999,1.0000	1.3870			0.07,0.81	16.29					-0.0095	0.9153	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr11	64572018	64572018	T	C	hom		QUAL=8197;DP=256;AF=1.00;MQM=60;SAP=23;ABP=0	MEN1	missense	MEN1:ENST00000312049.6:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:PF05053 [Menin],MEN1:ENST00000315422.4:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:PF05053 [Menin],MEN1:ENST00000337652.1:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000377313.1:missense_variant:MODERATE:exon9/9:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000377316.2:missense_variant:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala:PF05053 [Menin],MEN1:ENST00000377321.1:missense_variant:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala:PF05053 [Menin],MEN1:ENST00000377326.3:missense_variant:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala:PF05053 [Menin],MEN1:ENST00000394374.2:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000394376.1:missense_variant:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala:PF05053 [Menin],MEN1:ENST00000443283.1:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:PF05053 [Menin]	MEN1:NM_000244.3:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_001370251.1:synonymous_variant:LOW:exon11/11:c.1747A>G:p.Ala583=:,MEN1:NM_001370259.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370260.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370261.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370262.1:synonymous_variant:LOW:exon10/10:c.1516A>G:p.Ala506=:,MEN1:NM_001370263.1:synonymous_variant:LOW:exon10/10:c.1516A>G:p.Ala506=:,MEN1:NM_130799.2:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_130800.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130801.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130802.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130803.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130804.2:synonymous_variant:LOW:exon11/11:c.1636A>G:p.Ala546=:	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	613733 [GENE=MEN1 PHENOS=Lipoma,somatic/Angiofibroma,somatic/Multiple endocrine neoplasia 1,131100,Autosomal dominant/Carcinoid tumor of lung/Adrenal adenoma,somatic/Parathyroid adenoma,somatic];	134640 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs2959656	0.8345	0.9374	12830,.	0.7063,0.8813,0.6972,0.9960,0.9949	0.1310	T(0.77),T(0.77),T(0.76),T(0.76),T(0.76),T(0.75),T(0.77),T(0.76),T(0.76),T(0.76)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.01,0.39	11.00	0.30			COSV53639974	0.038	0.9201	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64572557	64572557	A	G	hom		QUAL=6551;DP=203;AF=1.00;MQM=60;SAP=38;ABP=0	MEN1	synonymous,intron	MEN1:ENST00000312049.6:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000315422.4:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000337652.1:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000377313.1:synonymous_variant:LOW:exon8/9:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000377316.2:intron_variant:MODIFIER:intron7/7:c.1186-269T>C::,MEN1:ENST00000377321.1:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:PF05053 [Menin],MEN1:ENST00000377326.3:synonymous_variant:LOW:exon8/9:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000394374.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000394376.1:synonymous_variant:LOW:exon10/11:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000443283.1:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin]	MEN1:NM_000244.3:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_001370251.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:,MEN1:NM_001370259.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370260.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370261.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370262.1:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:,MEN1:NM_001370263.1:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:,MEN1:NM_130799.2:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_130800.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130801.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130802.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130803.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130804.2:synonymous_variant:LOW:exon10/11:c.1314T>C:p.His438=:	regulatory_region_variant:CTCF_binding_site	613733 [GENE=MEN1 PHENOS=Lipoma,somatic/Angiofibroma,somatic/Multiple endocrine neoplasia 1,131100,Autosomal dominant/Carcinoid tumor of lung/Adrenal adenoma,somatic/Parathyroid adenoma,somatic];	167288 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs540012		0.9942	15012,.	0.9189,0.9969,0.9999,0.9999,0.9999	-0.3000			0.07,0.89	8.17					0.0916	0.1411	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	108175394	108175394	T	C	het		QUAL=161;DP=14;AF=0.57;MQM=60;SAP=13;ABP=4	ATM	splice_region&intron	ATM:ENST00000278616.4:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:ENST00000452508.2:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::	ATM:NM_000051.3:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:NM_001351834.2:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::		607585 [GENE=ATM PHENOS=Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/T-cell prolymphocytic leukemia,somatic/Lymphoma,mantle cell,somatic];	132706 [benign/likely benign DISEASE=Triple-negative breast carcinoma,Malignant tumor of breast,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];			rs3092829	0.0132	0.0225	7,.	0.0057,0.0186,0.0003,0.0333,0.0061	1.1230			0.19,0.32	5.92		10.05>8.69	0.000/0.004		-0.2961	0.5689	0	41	1735	9 / 360	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108175462	108175462	G	A	het		QUAL=388;DP=30;AF=0.53;MQM=60;SAP=3;ABP=3	ATM	missense	ATM:ENST00000278616.4:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000452508.2:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:	ATM:NM_000051.3:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:NM_001351834.2:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:		607585 [GENE=ATM PHENOS=Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/T-cell prolymphocytic leukemia,somatic/Lymphoma,mantle cell,somatic];	128458 [benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.0669	0.1136	286,.	0.0227,0.0613,0.0063,0.1435,0.0772	6.3420	T(0.08),T(0.08)	B(0.02),B(0.02)	0.98,0.99	23.40	0.12			COSV53728020	-0.2021	0.3688	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108183167	108183167	A	G	hom		QUAL=14140;DP=443;AF=1.00;MQM=60;SAP=5;ABP=0	ATM,C11orf65	missense,intron	ATM:ENST00000278616.4:missense_variant:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser:,ATM:ENST00000452508.2:missense_variant:MODERATE:exon41/64:c.5948A>G:p.Asn1983Ser:,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.641-3369T>C::	ATM:NM_000051.3:synonymous_variant:LOW:exon40/63:c.5948A>G:p.Ser1983=:,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.641-3369T>C::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron8/8:c.*39-3369T>C::,ATM:NM_001351834.2:synonymous_variant:LOW:exon41/64:c.5948A>G:p.Ser1983=:		607585 [GENE=ATM PHENOS=Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/T-cell prolymphocytic leukemia,somatic/Lymphoma,mantle cell,somatic];	133627 [benign DISEASE=Ataxia-telangiectasia syndrome,not specified];			rs659243	1.0000	1.0000	15702,.	1.0000,1.0000,1.0000,1.0000,1.0000	-1.0580	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.01,0.17	7.88	0.02				-0.1804	0.3005	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	125525195	125525195	A	G	hom		QUAL=1971;DP=59;AF=1.00;MQM=60;SAP=11;ABP=0	CHEK1	missense	CHEK1:ENST00000278916.3:missense_variant:MODERATE:exon11/11:c.1279A>G:p.Ile427Val:,CHEK1:ENST00000427383.2:missense_variant:MODERATE:exon12/12:c.1459A>G:p.Ile487Val:,CHEK1:ENST00000428830.2:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000438015.1:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000524737.1:missense_variant:MODERATE:exon12/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000534070.1:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000544373.1:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:	CHEK1:NM_001114121.2:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:NM_001114122.2:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:NM_001244846.1:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:,CHEK1:NM_001274.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:NM_001330427.1:missense_variant:MODERATE:exon12/13:c.1459A>G:p.Ile487Val:,CHEK1:NM_001330428.1:missense_variant:MODERATE:exon12/12:c.1129A>G:p.Ile377Val:,CHEK1:NR_045204.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2084A>G::,CHEK1:NR_045205.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1845A>G::			496139 [benign DISEASE=not provided];			rs506504		0.9771	14990,.	0.9950,0.9844,0.9996,0.9627,0.9798	1.1800	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.13,0.94	14.52	0.05				-0.2008	0.9544	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr13	32911888	32911888	A	G	het		QUAL=835;DP=75;AF=0.49;MQM=60;SAP=8;ABP=3	BRCA2	synonymous	BRCA2:ENST00000380152.3:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000544455.1:synonymous_variant:LOW:exon11/28:c.3396A>G:p.Lys1132=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:		600185 [GENE=BRCA2 PHENOS=Fanconi anemia,complementation group D1,605724,Autosomal recessive/Glioblastoma 3,613029,Autosomal recessive/Medulloblastoma,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Pancreatic cancer 2,613347/Wilms tumor,194070,Autosomal dominant,Somatic mutation];	126010 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM2110542 [CLASS=DM? MUT=ALT PHEN="Breast cancer" GENE=BRCA2];		rs1801406	0.2668	0.2976	1426,.	0.2282,0.2127,0.3820,0.3086,0.2989	0.2130			0.49,0.90	7.45				COSV66448451	0.0033	0.158	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32913055	32913055	A	G	hom		QUAL=32017;DP=989;AF=1.00;MQM=60;SAP=9;ABP=0	BRCA2	synonymous	BRCA2:ENST00000380152.3:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat],BRCA2:ENST00000544455.1:synonymous_variant:LOW:exon11/28:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat]	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:		600185 [GENE=BRCA2 PHENOS=Fanconi anemia,complementation group D1,605724,Autosomal recessive/Glioblastoma 3,613029,Autosomal recessive/Medulloblastoma,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Pancreatic cancer 2,613347/Wilms tumor,194070,Autosomal dominant,Somatic mutation];	132779 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs206075		0.9944	15079,.	0.9257,0.9957,0.9999,0.9996,0.9999	0.0710			0.00,0.27	2.65					0.0008	0.1579	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32915005	32915005	G	C	hom		QUAL=857;DP=26;AF=1.00;MQM=60;SAP=15;ABP=0	BRCA2	synonymous	BRCA2:ENST00000380152.3:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000544455.1:synonymous_variant:LOW:exon11/28:c.6513G>C:p.Val2171=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:	regulatory_region_variant:promoter_flanking_region	600185 [GENE=BRCA2 PHENOS=Fanconi anemia,complementation group D1,605724,Autosomal recessive/Glioblastoma 3,613029,Autosomal recessive/Medulloblastoma,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Pancreatic cancer 2,613347/Wilms tumor,194070,Autosomal dominant,Somatic mutation];	132780 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs206076		0.9942	15085,.	0.9253,0.9956,0.9999,0.9996,0.9999	-0.8750			0.02,0.13	0.11					-0.001	0.1579	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32929232	32929232	A	G	het		QUAL=437;DP=38;AF=0.50;MQM=60;SAP=4;ABP=3	BRCA2	synonymous	BRCA2:ENST00000380152.3:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000544455.1:synonymous_variant:LOW:exon14/28:c.7242A>G:p.Ser2414=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:		600185 [GENE=BRCA2 PHENOS=Fanconi anemia,complementation group D1,605724,Autosomal recessive/Glioblastoma 3,613029,Autosomal recessive/Medulloblastoma,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Pancreatic cancer 2,613347/Wilms tumor,194070,Autosomal dominant,Somatic mutation];	126133 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs1799955	0.2326	0.2289	855,.	0.2155,0.1799,0.3820,0.2162,0.2199	0.0900			0.06,0.30	8.15				COSV66447569	0.0672	0.5269	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32929387	32929387	T	C	hom		QUAL=19385;DP=598;AF=1.00;MQM=60;SAP=5;ABP=0	BRCA2	missense	BRCA2:ENST00000380152.3:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000544455.1:missense_variant:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon14/27:c.7397T>C:p.Ala2466=:		600185 [GENE=BRCA2 PHENOS=Fanconi anemia,complementation group D1,605724,Autosomal recessive/Glioblastoma 3,613029,Autosomal recessive/Medulloblastoma,155255,Autosomal dominant,Autosomal recessive,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Pancreatic cancer 2,613347/Wilms tumor,194070,Autosomal dominant,Somatic mutation];	133738 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 2,Ductal breast carcinoma,not specified,none provided];			rs169547	0.9758	0.9949	15141,.	0.9326,0.9960,0.9999,0.9997,0.9999	2.3520	T(1.00),T(1.00)	B(0.00),B(0.00)	0.00,0.10	11.56	0.09			COSV66451785	0.1306	0.5302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr14	45606387	45606387	A	G	het		QUAL=593;DP=53;AF=0.47;MQM=60;SAP=5;ABP=3	FANCM	missense	FANCM:ENST00000267430.5:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000542564.2:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000556036.1:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase]	FANCM:NM_001308133.2:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:,FANCM:NM_001308134.1:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:,FANCM:NM_020937.4:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:	regulatory_region_variant:promoter	609644 [GENE=FANCM PHENOS=Premature ovarian failure 15,618096,Autosomal recessive/Spermatogenic failure 28,618086,Autosomal recessive];	241326 [benign/likely benign DISEASE=Fanconi anemia,not specified,not provided];			rs45547534	0.0054	0.0102	3,.	0.0026,0.0066,0.0000,0.0156,0.0102	0.1240	D(0.00),D(0.00),D(0.00)	D(0.94),D(0.97),P(0.78)	0.70,0.96	23.40	0.12				0.2945	0.954	0.13	6	606	2 / 100	2	"[2] Ilnaz Sepahi 12-10-2016 batch import"			FKBP3 (inh=n/a oe_syn=1.05 oe_mis=1.00 oe_lof=0.54), FANCM (inh=AR oe_syn=1.00 oe_mis=1.01 oe_lof=0.46)
chr14	104165753	104165753	G	A	het		QUAL=12821;DP=959;AF=0.52;MQM=60;SAP=3;ABP=5	KLC1,XRCC3	intron,missense	KLC1:ENST00000334553.6:intron_variant:MODIFIER:intron15/16:c.1849-1239G>A::,KLC1:ENST00000348520.6:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::,XRCC3:ENST00000352127.7:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000445556.1:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000452929.2:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,XRCC3:ENST00000553264.1:missense_variant:MODERATE:exon6/8:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000554280.1:intron_variant:MODIFIER:intron14/15:c.1755-1239G>A::,XRCC3:ENST00000554913.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000554974.1:missense_variant:MODERATE:exon2/4:c.107C>T:p.Thr36Met:PF08423 [Rad51],XRCC3:ENST00000555055.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000555836.1:intron_variant:MODIFIER:intron15/16:c.1822-1239G>A::,KLC1:ENST00000557450.1:intron_variant:MODIFIER:intron13/14:c.1624-1239G>A::	XRCC3:NM_001100118.2:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:,XRCC3:NM_001100119.2:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,KLC1:NM_001130107.1:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,XRCC3:NM_001371229.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_001371231.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_001371232.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_005432.4:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,KLC1:NM_182923.3:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::	regulatory_region_variant:promoter_flanking_region	600675 [GENE=XRCC3 PHENOS=Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Melanoma,cutaneous malignant,6,613972];	8944 [risk factor DISEASE=Cutaneous malignant melanoma 6];	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3];		rs861539	0.2169	0.2931	1480,.	0.2066,0.1733,0.0546,0.3767,0.2435	0.6410	 , ,T(0.17),T(0.17), ,T(0.17), ,T(0.17),T(0.13),T(0.17), , 	 , ,B(0.19),B(0.19), ,B(0.19), ,B(0.19),B(0.19),B(0.19), , 	0.41,0.16	11.96	0.03				-0.0104	0.0958	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLC1 (inh=n/a oe_syn=1.01 oe_mis=0.52 oe_lof=0.23), XRCC3 (inh=AD oe_syn=1.06 oe_mis=0.92 oe_lof=1.13)
chr15	43701947	43701947	A	-	het		QUAL=548;DP=58;AF=0.43;MQM=60;SAP=5;ABP=5	TP53BP1	splice_region&intron	TP53BP1:ENST00000263801.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TP53BP1:ENST00000382039.3:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TP53BP1:ENST00000382044.4:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TP53BP1:ENST00000450115.2:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::	TP53BP1:NM_001141979.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::,TP53BP1:NM_001141980.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TUBGCP4:NM_001286414.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:NM_001355001.2:splice_region_variant&intron_variant:LOW:intron25/28:c.2426-8del::,TP53BP1:NM_005657.4:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TUBGCP4:NM_014444.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::		609610 [GENE=TUBGCP4 PHENOS=Microcephaly and chorioretinopathy,autosomal recessive,3,616335,Autosomal recessive];				rs56813954		0.3535	751,.	0.1846,0.3650,0.4202,0.3555,0.3896	0.7510				8.12					-0.0467	0.0936	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43707808	43707808	A	T	het		QUAL=1611;DP=136;AF=0.46;MQM=60;SAP=15;ABP=5	TP53BP1	synonymous	TP53BP1:ENST00000263801.3:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:,TP53BP1:ENST00000382039.3:synonymous_variant:LOW:exon22/27:c.4923T>A:p.Ser1641=:,TP53BP1:ENST00000382044.4:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:ENST00000450115.2:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:	TP53BP1:NM_001141979.3:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:NM_001141980.3:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:NM_001355001.2:synonymous_variant:LOW:exon24/29:c.2193T>A:p.Ser731=:,TP53BP1:NM_005657.4:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:						rs2230451	0.1286	0.1602	429,.	0.1698,0.1011,0.0024,0.1892,0.2102	0.1810			0.62,0.96	10.94					-0.0314	0.8666	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43724646	43724646	T	G	hom		QUAL=20035;DP=634;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	missense	TP53BP1:ENST00000263801.3:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:,TP53BP1:ENST00000382039.3:missense_variant:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000382044.4:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000450115.2:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:NM_001355001.2:missense_variant:MODERATE:exon18/29:c.541A>C:p.Lys181Gln:,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:				CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs2602141	0.5264	0.4413	4130,.	0.8589,0.3182,0.4142,0.3018,0.4497	3.2620	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.01,0.91	18.81	0.08				0.0253	0.2685	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43748304	43748304	A	G	hom		QUAL=30192;DP=958;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	synonymous	TP53BP1:ENST00000263801.3:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:,TP53BP1:ENST00000382039.3:synonymous_variant:LOW:exon12/27:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000382044.4:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000450115.2:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:	TP53BP1:NM_001141979.3:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:NM_001141980.3:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon12/29:c.-528T>C::,TP53BP1:NM_005657.4:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:						rs690367		0.4454	4244,.	0.8732,0.3186,0.4142,0.3016,0.4349	1.1610			0.02,0.13	1.49				COSV55506600	0.0129	0.3074	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43762196	43762196	C	T	het		QUAL=3267;DP=207;AF=0.57;MQM=60;SAP=7;ABP=13	TP53BP1	missense	TP53BP1:ENST00000263801.3:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:,TP53BP1:ENST00000382039.3:missense_variant:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000382044.4:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000450115.2:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon11/29:c.-1781G>A::,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:				CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1];		rs689647	0.3824	0.2721	2057,.	0.6566,0.2149,0.4114,0.1121,0.2250	1.1390	T(0.09),T(0.09),T(0.09),T(0.09)	B(0.00),B(0.00),B(0.00),B(0.00)	0.20,0.80	18.38	0.07			COSV55506613	-0.2152	0.2971	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43767774	43767774	G	C	hom		QUAL=3605;DP=116;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	missense	TP53BP1:ENST00000263801.3:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:,TP53BP1:ENST00000382039.3:missense_variant:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000382044.4:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000450115.2:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon9/29:c.-1956C>G::,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:				CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs560191		0.4453	4249,.	0.8730,0.3178,0.4140,0.3015,0.4352	0.2260	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.08,0.92	14.95	0.24				0.1848	0.2374	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr16	3639139	3639139	A	G	het		QUAL=1353;DP=101;AF=0.52;MQM=60;SAP=5;ABP=4	SLX4	synonymous	SLX4:ENST00000294008.3:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:	SLX4:NM_032444.4:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:		613278 [GENE=SLX4 PHENOS=Fanconi anemia,complementation group P,613951,Autosomal recessive];	262053 [benign DISEASE=Fanconi anemia, complementation group P,Fanconi anemia,not specified,not provided];			rs3810812		0.6325	6710,.	0.8780,0.6691,0.7202,0.5133,0.7614	0.7190			0.00,0.15	1.21					0.0145	0.0938	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	3639230	3639230	G	A	het		QUAL=1429;DP=111;AF=0.50;MQM=60;SAP=3;ABP=3	SLX4	missense	SLX4:ENST00000294008.3:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:	SLX4:NM_032444.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:		613278 [GENE=SLX4 PHENOS=Fanconi anemia,complementation group P,613951,Autosomal recessive];	885261 [uncertain significance DISEASE=Fanconi anemia, complementation group P,Fanconi anemia];	CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4];		rs72778139	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0002,0.0000	0.3390	T(0.16)	B(0.06)	0.25,0.84	19.12	0.11			COSV53560456	0.0011	0.0935	0	0	43	0 / 4					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	68771372	68771372	C	T	hom		QUAL=4018;DP=128;AF=0.99;MQM=60;SAP=3;ABP=0	CDH1	splice_region&intron	CDH1:ENST00000261769.5:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::,CDH1:ENST00000422392.2:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::	CDH1:NM_001317184.2:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::,CDH1:NM_001317185.2:splice_region_variant&intron_variant:LOW:intron1/15:c.-1568+6C>T::,CDH1:NM_001317186.2:splice_region_variant&intron_variant:LOW:intron1/14:c.-1772+6C>T::,CDH1:NM_004360.5:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::	regulatory_region_variant:promoter	192090 [GENE=CDH1 PHENOS=Ovarian cancer,somatic,167000/Blepharocheilodontic syndrome 1,119580,Autosomal dominant/Endometrial carcinoma,somatic,608089/Breast cancer,lobular,114480,Autosomal dominant,Somatic mutation/Gastric cancer,hereditary diffuse,with or without cleft lip and/or palate,137215,Autosomal dominant/Prostate cancer,susceptibility to,176807,Autosomal dominant,Somatic mutation];	136692 [benign DISEASE=Malignant tumor of prostate,Hereditary diffuse gastric cancer,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Blepharocheilodontic syndrome 1,not specified,none provided,not provided];			rs3743674	0.7634	0.8161	10198,.	0.6465,0.7409,0.7648,0.8784,0.7780	-0.1880			0.00,0.15	6.29		8.63>8.16	0.000/0.032		-0.132	0.3636	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68857441	68857441	T	C	het		QUAL=14799;DP=1140;AF=0.52;MQM=60;SAP=3;ABP=9	CDH1	synonymous	CDH1:ENST00000261769.5:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:,CDH1:ENST00000422392.2:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:	CDH1:NM_001317184.2:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:,CDH1:NM_001317185.2:synonymous_variant:LOW:exon13/16:c.528T>C:p.Ala176=:,CDH1:NM_001317186.2:synonymous_variant:LOW:exon12/15:c.111T>C:p.Ala37=:,CDH1:NM_004360.5:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:	regulatory_region_variant:TF_binding_site,TF_binding_site_variant	192090 [GENE=CDH1 PHENOS=Ovarian cancer,somatic,167000/Blepharocheilodontic syndrome 1,119580,Autosomal dominant/Endometrial carcinoma,somatic,608089/Breast cancer,lobular,114480,Autosomal dominant,Somatic mutation/Gastric cancer,hereditary diffuse,with or without cleft lip and/or palate,137215,Autosomal dominant/Prostate cancer,susceptibility to,176807,Autosomal dominant,Somatic mutation];	142770 [benign DISEASE=Malignant tumor of prostate,Hereditary diffuse gastric cancer,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Blepharocheilodontic syndrome 1,not specified,none provided,not provided];	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1];		rs1801552	0.7187	0.6957	7780,.	0.8906,0.6658,0.6503,0.6253,0.6535	-0.0840			0.00,0.10	5.66					0.0748	0.3653	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	89836323	89836323	C	T	het		QUAL=829;DP=95;AF=0.40;MQM=60;SAP=14;ABP=11	FANCA	missense	FANCA:ENST00000389301.3:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000568369.1:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:	FANCA:NM_000135.4:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	134254 [benign DISEASE=Fanconi anemia, complementation group A,Fanconi anemia,not specified,not provided];	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA];		rs7195066	0.6667	0.4729	4050,.	0.6757,0.6527,0.9854,0.3093,0.5889	0.3050	T(0.31),T(0.31)	B(0.00),B(0.00)	0.02,0.14	12.82	0.20				-0.8381	0.9724	0.41	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89838078	89838078	A	G	het		QUAL=12928;DP=1057;AF=0.49;MQM=60;SAP=3;ABP=5	FANCA	splice_region&intron	FANCA:ENST00000389301.3:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000568369.1:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::	FANCA:NM_000135.4:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:NM_001286167.3:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	255245 [benign DISEASE=Fanconi anemia, complementation group A,Fanconi anemia,not specified];			rs1800340	0.5599	0.4376	2827,.	0.5199,0.6353,0.7430,0.3035,0.5709	-0.8300			0.02,0.11	0.12			0.000/0.000		0.5986	0.017	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89849480	89849480	C	T	hom		QUAL=6739;DP=202;AF=1.00;MQM=60;SAP=83;ABP=0	FANCA	missense	FANCA:ENST00000389301.3:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:,FANCA:ENST00000568369.1:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:	FANCA:NM_000135.4:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	134244 [benign DISEASE=Fanconi anemia, complementation group A,Fanconi anemia,not specified,not provided];	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs2239359	0.6240	0.5205	4551,.	0.6922,0.6207,0.8561,0.3908,0.4927	-0.0380	T(1.00),T(1.00)	B(0.00),B(0.00)	0.02,0.16	0.03	0.26				-0.0985	0.1132	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89866043	89866043	T	C	het		QUAL=9341;DP=729;AF=0.49;MQM=60;SAP=3;ABP=3	FANCA	missense	FANCA:ENST00000389301.3:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:ENST00000389302.3:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:,FANCA:ENST00000534992.1:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:,FANCA:ENST00000543736.1:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:,FANCA:ENST00000563673.1:missense_variant:MODERATE:exon9/10:c.796A>G:p.Thr266Ala:,FANCA:ENST00000568369.1:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:	FANCA:NM_000135.4:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:NM_001018112.3:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:NM_001351830.2:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:		607139 [GENE=FANCA PHENOS=Fanconi anemia,complementation group A,227650,Autosomal recessive];	134294 [benign DISEASE=Malignant tumor of breast,Fanconi anemia, complementation group A,Fanconi anemia,not specified,not provided];	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs7190823	0.6905	0.5318	4872,.	0.7249,0.6678,0.9844,0.3847,0.5899	0.4020	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.25	5.62	0.08				0.2453	0.3475	0.25	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr17	7579472	7579472	G	C	het		QUAL=7653;DP=570;AF=0.54;MQM=60;SAP=4;ABP=10	TP53	missense	TP53:ENST00000269305.4:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000359597.4:missense_variant:MODERATE:exon3/9:c.215C>G:p.Pro72Arg:,TP53:ENST00000413465.2:missense_variant:MODERATE:exon3/7:c.215C>G:p.Pro72Arg:,TP53:ENST00000420246.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000445888.2:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000455263.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:	TP53:NM_000546.5:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:NM_001126112.2:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:NM_001126113.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:NM_001126114.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:NM_001126118.1:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:NM_001276695.2:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:NM_001276696.2:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:NM_001276760.2:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:NM_001276761.2:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:		191170 [GENE=TP53 PHENOS=Basal cell carcinoma 7,614740,Autosomal dominant/Adrenocortical carcinoma,pediatric,202300,Autosomal dominant/Hepatocellular carcinoma,somatic,114550/Breast cancer,somatic,114480/Li-Fraumeni syndrome,151623,Autosomal dominant/Pancreatic cancer,somatic,260350/Nasopharyngeal carcinoma,somatic,607107/Osteosarcoma,259500,Somatic mutation/Choroid plexus papilloma,260500,Autosomal dominant/Colorectal cancer,114500,Autosomal dominant,Somatic mutation/Glioma susceptibility 1,137800,Autosomal dominant,Somatic mutation/Bone marrow failure syndrome 5,618165,Autosomal dominant];	12351 [drug response DISEASE=CODON 72 POLYMORPHISM,Li-Fraumeni syndrome 1,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lip and oral cavity carcinoma,not specified,none provided,antineoplastic agents response - Efficacy, Toxicity/ADR,cisplatin response - Efficacy, Toxicity/ADR,cyclophosphamide response - Efficacy, Toxicity/ADR,fluorouracil response - Efficacy, Toxicity/ADR,paclitaxel response - Efficacy, Toxicity/ADR,not provided];			rs1042522		0.6682	6369,.	0.3799,0.7145,0.5700,0.7378,0.5002	1.0160	T(0.57),T(0.36),T(0.24),T(0.26),T(0.57),T(0.37)	B(0.05),B(0.35),B(0.37),B(0.13),B(0.05),B(0.15)	0.36,0.50	9.18	0.37			COSV52666208,COSV53098660	0.0506	0.2351	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahpohla1 15.04.2019"			TP53 (inh=AR+AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	29553485	29553485	G	A	hom		QUAL=2514;DP=83;AF=1.00;MQM=60;SAP=25;ABP=0	NF1	synonymous	NF1:ENST00000356175.3:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:ENST00000358273.4:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:	NF1:NM_000267.3:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:NM_001042492.3:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:	regulatory_region_variant:promoter_flanking_region	613113 [GENE=NF1 PHENOS=Watson syndrome,193520,Autosomal dominant/Leukemia,juvenile myelomonocytic,607785,Autosomal dominant,Somatic mutation/Neurofibromatosis,familial spinal,162210,Autosomal dominant/Neurofibromatosis,type 1,162200,Autosomal dominant/Neurofibromatosis-Noonan syndrome,601321,Autosomal dominant];	183826 [benign DISEASE=Neurofibromatosis, familial spinal,Cafe-au-lait macules with pulmonary stenosis,Neurofibromatosis-Noonan syndrome,Hereditary cancer-predisposing syndrome,Neurofibromatosis, type 1,not specified,none provided,not provided];			rs2285892	0.4968	0.4348	3349,.	0.6830,0.4940,0.5192,0.3012,0.3700	-1.2980			0.04,0.37	5.66					-0.0802	0.2782	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	33433487	33433487	C	T	hom		QUAL=2531;DP=85;AF=1.00;MQM=60;SAP=46;ABP=0	RAD51D,RAD51L3-RFFL	missense	RAD51D:ENST00000335858.7:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:PF08423 [Rad51],RAD51D:ENST00000345365.6:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000360276.3:missense_variant:MODERATE:exon5/9:c.359G>A:p.Arg120Gln:,RAD51D:ENST00000394589.4:missense_variant:MODERATE:exon7/11:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000460118.2:missense_variant:MODERATE:exon5/9:c.137G>A:p.Arg46Gln:PF08423 [Rad51],RAD51D:ENST00000590016.1:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:PF13481 [AAA domain],RAD51L3-RFFL:ENST00000593039.1:missense_variant:MODERATE:exon2/7:c.17G>A:p.Arg6Gln:	RAD51D:NM_001142571.2:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:,RAD51D:NM_002878.3:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:,RAD51D:NM_133629.3:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:,RAD51D:NR_037711.2:non_coding_transcript_exon_variant:MODIFIER:exon5/9:n.520G>A::,RAD51D:NR_037712.2:non_coding_transcript_exon_variant:MODIFIER:exon4/8:n.385G>A::,RAD51L3-RFFL:NR_037714.1:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.246G>A::		602954 [GENE=RAD51D PHENOS=Breast-ovarian cancer,familial,susceptibility to,4,614291];	142159 [benign DISEASE=Breast-ovarian cancer, familial 4,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM172631 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=RAD51D];		rs4796033	0.0951	0.1555	303,.	0.0296,0.2950,0.0455,0.1414,0.1630	1.3250	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.01),B(0.00)	0.04,0.89	15.73	0.13				-0.3303	0.9421	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 08.05.2018: AF 15% in gnomAD und ExAC"			RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	33445549	33445549	G	A	het		QUAL=1656;DP=131;AF=0.55;MQM=60;SAP=7;ABP=6	RAD51D,RAD51L3-RFFL	intron,synonymous,5'UTR	RAD51D:ENST00000335858.7:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:ENST00000345365.6:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000357906.3:synonymous_variant:LOW:exon3/4:c.234C>T:p.Ser78=:,RAD51D:ENST00000360276.3:synonymous_variant:LOW:exon3/9:c.234C>T:p.Ser78=:,RAD51D:ENST00000394589.4:synonymous_variant:LOW:exon4/11:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000460118.2:5_prime_UTR_variant:MODIFIER:exon3/9:c.-42C>T::,RAD51D:ENST00000590016.1:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51L3-RFFL:ENST00000593039.1:intron_variant:MODIFIER:intron1/6:c.3+2761C>T::	RAD51D:NM_001142571.2:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51D:NM_002878.3:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:,RAD51D:NM_133629.3:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:NR_037711.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.289+581C>T::,RAD51D:NR_037712.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.289+581C>T::,RAD51L3-RFFL:NR_037714.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.232+2761C>T::	regulatory_region_variant:CTCF_binding_site	602954 [GENE=RAD51D PHENOS=Breast-ovarian cancer,familial,susceptibility to,4,614291];	183785 [benign DISEASE=Breast-ovarian cancer, familial 4,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs9901455	0.1875	0.1616	563,.	0.3055,0.1043,0.2299,0.0821,0.0860	1.6530			0.64,0.92	17.80					-0.0467	0.6691	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80), FNDC8 (inh=n/a oe_syn=0.99 oe_mis=0.91 oe_lof=0.69)
chr17	41223094	41223094	T	C	het		QUAL=4362;DP=432;AF=0.47;MQM=60;SAP=269;ABP=6	BRCA1	missense,intron	BRCA1:ENST00000309486.4:missense_variant:MODERATE:exon14/22:c.3949A>G:p.Ser1317Gly:,BRCA1:ENST00000346315.3:intron_variant:MODIFIER:intron12/18:c.4358-7126A>G::,BRCA1:ENST00000351666.3:missense_variant:MODERATE:exon11/19:c.1288A>G:p.Ser430Gly:,BRCA1:ENST00000352993.3:missense_variant:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly:,BRCA1:ENST00000354071.3:intron_variant:MODIFIER:intron12/17:c.4358-7704A>G::,BRCA1:ENST00000357654.3:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000468300.1:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000471181.2:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:ENST00000491747.2:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000493795.1:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:ENST00000586385.1:intron_variant:MODIFIER:intron1/7:c.5-7126A>G::,BRCA1:ENST00000591534.1:missense_variant:MODERATE:exon3/11:c.310A>G:p.Ser104Gly:,BRCA1:ENST00000591849.1:intron_variant:MODIFIER:intron1/4:c.-98-20887A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:NM_007298.3:missense_variant:MODERATE:exon14/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007299.4:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007300.4:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon15/23:n.5014A>G::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial/Pancreatic cancer,susceptibility to,4,614320];	41827 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial 1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799966	0.3558	0.3539	1623,.	0.2404,0.3171,0.3801,0.3259,0.5041	-0.1120	T(0.14), ,T(0.14),T(0.11), ,T(0.11),T(0.12),T(0.12),T(0.10),T(0.11), ,T(0.20), 	B(0.04), ,B(0.01),B(0.01), ,B(0.04),B(0.00),B(0.07),B(0.02),B(0.04), ,B(0.04), 	0.03,0.18	9.51	0.25			COSV58783381	-0.0744	0.319	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41234470	41234470	A	G	het		QUAL=343;DP=34;AF=0.50;MQM=60;SAP=25;ABP=3	BRCA1	synonymous,intron	BRCA1:ENST00000309486.4:synonymous_variant:LOW:exon11/22:c.3420T>C:p.Ser1140=:,BRCA1:ENST00000346315.3:synonymous_variant:LOW:exon12/19:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000351666.3:synonymous_variant:LOW:exon8/19:c.759T>C:p.Ser253=:,BRCA1:ENST00000352993.3:synonymous_variant:LOW:exon11/22:c.882T>C:p.Ser294=:,BRCA1:ENST00000354071.3:synonymous_variant:LOW:exon12/18:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000357654.3:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000468300.1:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:ENST00000471181.2:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000491747.2:synonymous_variant:LOW:exon12/23:c.999T>C:p.Ser333=:,BRCA1:ENST00000493795.1:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:ENST00000586385.1:intron_variant:MODIFIER:intron1/7:c.5-18502T>C::,BRCA1:ENST00000591534.1:intron_variant:MODIFIER:intron1/10:c.-43-7932T>C::,BRCA1:ENST00000591849.1:intron_variant:MODIFIER:intron1/4:c.-98-32263T>C::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:NM_007298.3:synonymous_variant:LOW:exon11/22:c.999T>C:p.Ser333=:,BRCA1:NM_007299.4:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:NM_007300.4:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon12/23:n.4485T>C::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial/Pancreatic cancer,susceptibility to,4,614320];	125703 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1719086 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1060915	0.3363	0.3485	1511,.	0.1820,0.3116,0.3787,0.3255,0.5038	-0.1190			0.04,0.21	2.72					-0.001	0.3454	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	41244000	41244000	T	C	het		QUAL=4694;DP=350;AF=0.49;MQM=60;SAP=4;ABP=3	BRCA1	missense,intron	BRCA1:ENST00000309486.4:missense_variant:MODERATE:exon9/22:c.2660A>G:p.Lys887Arg:,BRCA1:ENST00000346315.3:missense_variant:MODERATE:exon10/19:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000351666.3:intron_variant:MODIFIER:intron6/18:c.548-951A>G::,BRCA1:ENST00000352993.3:intron_variant:MODIFIER:intron9/21:c.671-951A>G::,BRCA1:ENST00000354071.3:missense_variant:MODERATE:exon10/18:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000357654.3:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000468300.1:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:ENST00000471181.2:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000491747.2:intron_variant:MODIFIER:intron10/22:c.788-951A>G::,BRCA1:ENST00000493795.1:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:ENST00000586385.1:intron_variant:MODIFIER:intron1/7:c.5-28032A>G::,BRCA1:ENST00000591534.1:intron_variant:MODIFIER:intron1/10:c.-43-17462A>G::,BRCA1:ENST00000591849.1:intron_variant:MODIFIER:intron1/4:c.-99+33288A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-951A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3725A>G::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial/Pancreatic cancer,susceptibility to,4,614320];	41818 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1];		rs16942	0.3526	0.3527	1591,.	0.2365,0.3164,0.3795,0.3242,0.5039	-0.3660	T(1.00),T(1.00), , ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	B(0.00),B(0.00), , ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	0.02,0.17	0.11	0.07			COSV58784397	0.0032	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41244435	41244435	T	C	het		QUAL=10833;DP=980;AF=0.49;MQM=60;SAP=4;ABP=5	BRCA1	missense,intron	BRCA1:ENST00000309486.4:missense_variant:MODERATE:exon9/22:c.2225A>G:p.Glu742Gly:,BRCA1:ENST00000346315.3:missense_variant:MODERATE:exon10/19:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000351666.3:intron_variant:MODIFIER:intron6/18:c.548-1386A>G::,BRCA1:ENST00000352993.3:intron_variant:MODIFIER:intron9/21:c.671-1386A>G::,BRCA1:ENST00000354071.3:missense_variant:MODERATE:exon10/18:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000357654.3:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000468300.1:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:ENST00000471181.2:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000491747.2:intron_variant:MODIFIER:intron10/22:c.788-1386A>G::,BRCA1:ENST00000493795.1:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:ENST00000586385.1:intron_variant:MODIFIER:intron1/7:c.5-28467A>G::,BRCA1:ENST00000591534.1:intron_variant:MODIFIER:intron1/10:c.-43-17897A>G::,BRCA1:ENST00000591849.1:intron_variant:MODIFIER:intron1/4:c.-99+32853A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-1386A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3290A>G::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial/Pancreatic cancer,susceptibility to,4,614320];	41815 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial 1,Breast-ovarian cancer, familial 2,Pancreatic cancer 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,none provided,not provided];	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1];		rs16941	0.3357	0.3483	1505,.	0.1818,0.3112,0.3789,0.3252,0.5035	-0.4810	T(0.06),T(0.14), , ,T(0.13),T(0.16), ,T(0.17), ,T(0.15), , , 	P(0.61),B(0.01), , ,B(0.08),P(0.61), ,B(0.00), ,P(0.61), , , 	0.05,0.19	15.07	0.23			COSV58786412	0.0013	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41244936	41244936	G	A	het		QUAL=2121;DP=130;AF=0.58;MQM=60;SAP=9;ABP=11	BRCA1	missense,intron	BRCA1:ENST00000309486.4:missense_variant:MODERATE:exon9/22:c.1724C>T:p.Pro575Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000346315.3:missense_variant:MODERATE:exon10/19:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000351666.3:intron_variant:MODIFIER:intron6/18:c.548-1887C>T::,BRCA1:ENST00000352993.3:intron_variant:MODIFIER:intron9/21:c.671-1887C>T::,BRCA1:ENST00000354071.3:missense_variant:MODERATE:exon10/18:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000357654.3:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000468300.1:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:ENST00000471181.2:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000491747.2:intron_variant:MODIFIER:intron10/22:c.787+1825C>T::,BRCA1:ENST00000493795.1:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000586385.1:intron_variant:MODIFIER:intron1/7:c.5-28968C>T::,BRCA1:ENST00000591534.1:intron_variant:MODIFIER:intron1/10:c.-43-18398C>T::,BRCA1:ENST00000591849.1:intron_variant:MODIFIER:intron1/4:c.-99+32352C>T::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1825C>T::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2789C>T::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial/Pancreatic cancer,susceptibility to,4,614320];	41812 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917		0.4842	4287,.	0.8253,0.3484,0.3789,0.3338,0.5316	4.2470	T(1.00),T(1.00), , ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	B(0.00),B(0.00), , ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	0.02,0.89	18.04	0.14			COSV58784386	-0.0116	0.893	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41245237	41245237	A	G	het		QUAL=1538;DP=127;AF=0.46;MQM=60;SAP=3;ABP=5	BRCA1	synonymous,intron	BRCA1:ENST00000309486.4:synonymous_variant:LOW:exon9/22:c.1423T>C:p.Leu475=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000346315.3:synonymous_variant:LOW:exon10/19:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000351666.3:intron_variant:MODIFIER:intron6/18:c.548-2188T>C::,BRCA1:ENST00000352993.3:intron_variant:MODIFIER:intron9/21:c.671-2188T>C::,BRCA1:ENST00000354071.3:synonymous_variant:LOW:exon10/18:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000357654.3:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000468300.1:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:ENST00000471181.2:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000491747.2:intron_variant:MODIFIER:intron10/22:c.787+1524T>C::,BRCA1:ENST00000493795.1:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000586385.1:intron_variant:MODIFIER:intron1/7:c.5-29269T>C::,BRCA1:ENST00000591534.1:intron_variant:MODIFIER:intron1/10:c.-43-18699T>C::,BRCA1:ENST00000591849.1:intron_variant:MODIFIER:intron1/4:c.-99+32051T>C::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1524T>C::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:NM_007300.4:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2488T>C::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial/Pancreatic cancer,susceptibility to,4,614320];	125554 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Pancreatic cancer 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,none provided,not provided];	CM1719261 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs16940	0.3353	0.3474	1492,.	0.1815,0.3108,0.3790,0.3237,0.5033	-0.4510			0.06,0.19	5.58				COSV58786443	0.0045	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	41245466	41245466	G	A	het		QUAL=464;DP=62;AF=0.44;MQM=60;SAP=62;ABP=5	BRCA1	synonymous,intron	BRCA1:ENST00000309486.4:synonymous_variant:LOW:exon9/22:c.1194C>T:p.Ser398=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000346315.3:synonymous_variant:LOW:exon10/19:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000351666.3:intron_variant:MODIFIER:intron6/18:c.548-2417C>T::,BRCA1:ENST00000352993.3:intron_variant:MODIFIER:intron9/21:c.670+2397C>T::,BRCA1:ENST00000354071.3:synonymous_variant:LOW:exon10/18:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000357654.3:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000468300.1:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:ENST00000471181.2:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000491747.2:intron_variant:MODIFIER:intron10/22:c.787+1295C>T::,BRCA1:ENST00000493795.1:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000586385.1:intron_variant:MODIFIER:intron1/7:c.5-29498C>T::,BRCA1:ENST00000591534.1:intron_variant:MODIFIER:intron1/10:c.-43-18928C>T::,BRCA1:ENST00000591849.1:intron_variant:MODIFIER:intron1/4:c.-99+31822C>T::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1295C>T::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:NM_007300.4:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2259C>T::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial/Pancreatic cancer,susceptibility to,4,614320];	125536 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1719085 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799949	0.3365	0.3526	1602,.	0.2372,0.3165,0.3788,0.3242,0.5041	-0.0020			0.00,0.13	3.94				COSV58784419	-0.0079	0.8931	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	59760996	59760996	A	G	hom		QUAL=7636;DP=310;AF=1.00;MQM=60;SAP=676;ABP=0	BRIP1	synonymous	BRIP1:ENST00000259008.2:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:	BRIP1:NM_032043.3:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:		605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Autosomal dominant,Somatic mutation];	183702 [benign DISEASE=Neoplasm of ovary,Fanconi anemia, complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs4986763	0.6208	0.5993	5476,.	0.6543,0.7941,0.7150,0.5867,0.4553	3.1090			0.83,0.98	9.03					0.0046	0.9405	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	59763347	59763347	A	G	hom		QUAL=373;DP=12;AF=1.00;MQM=60;SAP=6;ABP=0	BRIP1	missense	BRIP1:ENST00000259008.2:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000577598.1:missense_variant:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro:	BRIP1:NM_032043.3:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:		605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Autosomal dominant,Somatic mutation];	133756 [benign DISEASE=Neoplasm of ovary,Fanconi anemia, complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs4986764	0.6278	0.6019	5608,.	0.6744,0.7994,0.7151,0.5875,0.4555	0.1360	T(0.94),T(0.43)	B(0.00),B(0.00)	0.00,0.15	1.50	0.09				-0.0403	0.9052	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	59763465	59763465	T	C	hom		QUAL=3671;DP=114;AF=1.00;MQM=60;SAP=107;ABP=0	BRIP1	synonymous	BRIP1:ENST00000259008.2:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:,BRIP1:ENST00000577598.1:synonymous_variant:LOW:exon18/18:c.2637A>G:p.Glu879=:	BRIP1:NM_032043.3:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:		605882 [GENE=BRIP1 PHENOS=Fanconi anemia,complementation group J,609054/Breast cancer,early-onset,susceptibility to,114480,Autosomal dominant,Somatic mutation];	183703 [benign DISEASE=Neoplasm of ovary,Fanconi anemia, complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs4986765	0.8151	0.7183	8462,.	0.9105,0.8670,0.8908,0.6633,0.6991	-0.0280			0.11,0.93	9.96					-0.0065	0.9053	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr19	17389648	17389648	C	T	het		QUAL=1232;DP=108;AF=0.47;MQM=60;SAP=3;ABP=4	BABAM1,CTD-2278I10.6	splice_region&intron,intron&NMD_transcript	BABAM1:ENST00000359435.4:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000447614.2:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000595632.1:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,CTD-2278I10.6:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.552+1930C>T::,BABAM1:ENST00000598188.1:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000601043.1:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::	BABAM1:NM_001033549.2:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288756.1:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288757.1:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:NM_014173.4:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::						rs10406920	0.1118	0.1847	572,.	0.1828,0.0790,0.0006,0.1783,0.1144	0.7670			0.22,0.33	3.11		8.04>7.99	0.000/0.002		-0.5749	0.9948	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr19	17389704	17389704	G	A	het		QUAL=6312;DP=539;AF=0.47;MQM=60;SAP=3;ABP=7	BABAM1,CTD-2278I10.6	synonymous,intron&NMD_transcript	BABAM1:ENST00000359435.4:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000447614.2:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000595632.1:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,CTD-2278I10.6:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.552+1986G>A::,BABAM1:ENST00000598188.1:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000601043.1:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:	BABAM1:NM_001033549.2:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288756.1:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288757.1:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:NM_014173.4:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:				CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1];		rs8170	0.1124	0.1865	577,.	0.1918,0.0800,0.0006,0.1795,0.1147	2.9920			0.88,0.94	11.44					-0.0872	0.9214	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
